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 Streptococcus agalactiae (Group B Streptococcus - GBS), Streptococcus dysgalactiae 
subsp. dysgalactiae (Group C Streptococcus - GCS) and Streptococcus uberis are relevant 
mastitis pathogens, a highly prevalent and costly disease in the dairy industry due to 
antibiotherapy and loss in milk production. However, molecular characterization of field 
isolates of Streptococcus spp. occurring in Portugal was not known prior to our studies and is 
important to improve therapeutic and disease control programs. The aims of this study were the 
identification of strain molecular features, and the evaluation of antimicrobial drug resistance 
patterns of S. agalactiae (n=60), S. dysgalactiae subsp. dysgalactiae (n=18) and S. uberis 
(n=30) collected from bovine subclinical mastitis between 2002/2003 in Portugal. 
Additionally, two S. dysgalactiae subsp. dysgalactiae strains associated with invasive disease 
(one collected from cattle and the other from a human), and six Streptococcus dysgalactiae 
subsp. equisimilis (group C or group G Streptococcus - GCS/GGS) strains from human 
infection were included in the study, for comparative purposes. 
 Genotypic relationships were identified using pulsed-field gel electrophoresis 
(PFGE)/BioNumerics, S. agalactiae and S. uberis multi-locus sequence typing (MLST), 
macrolide and tetracycline resistance gene profiling, S. agalactiae molecular serotyping, 
virulence gene profiling, PCR-amplification for screening presence of specific genes and 
subsequent sequencing for phylogenetic analysis, and reverse transcriptase-PCR (RT-PCR) for 
gene expression analysis of selected genes. Also, a custom-designed microarray containing 220 
virulence genes of the human pathogen Streptococcus pyogenes (Group A Streptococcus - 
GAS) was used to test bovine GCS S. dysgalactiae subsp. dysgalactiae and human GCS/GGS S. 
dysgalactiae subsp. equisimilis. Antimicrobial resistance was assessed by disk diffusion against 
penicillin, gentamicin, streptomycin, amoxicillin-clavulanic acid, cefazolin, cefoperazone, 
rifaximin, erythromycin, pirlimycin, tetracycline, vancomycin, chloramphenicol and the 
macrolide-lincosamide resistance phenotypes (cMLSB, iMLSB, M, L). 
 Among S. uberis three PFGE clonal groups (defined by at least 80% similarity) 
comprised almost half of total isolates, and 50% of GBS isolates were included in four major 
clonal groups (all farm-associated), which is indicative of a contagious route of transmission 
between animals. The occurrence of PFGE patterns sharing >82.8% and 100% similarity among 
S. dysgalactiae subsp. dysgalactiae isolates collected from different farms suggests an 
environmental source for this pathogen in our case. By MLST, we observed that all S. uberis 
sequence types (ST) were found to be novel (n=14), representing novel genomic backgrounds 
for this pathogen. Among GBS only three MLST lineages (ST-2, ST-23, and ST-61/ST-554) 
were detected revealing little heterogeneity among our bovine GBS collection. 
Five new cpsD-cpsE-cpsF sequences of the cps locus (encoding the capsular polysaccharide) 
were detected in >70% of the bovine GBS, which may represent new serotypes. Human GBS 
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insertion sequences were found in the cpsE gene (of the cps locus) in four bovine GBS isolates. 
Theses inserts probably disrupt the expression of the capsular polysaccharide in theses strains. 
Bovine GBS isolates (>20%) carry the laminin-binding protein and the C5a peptidase virulence 
genes (lmb and scpB), known to be required for human GBS strains to infect the human host. 
The remaining bovine GBS may have lost these genes during the adaptation to the bovine host. 
S. pyogenes bacteriophage-associated virulence genes (speC, speM, speK, speL, spd1, sdn) 
encoding superantigens, Dnase, and streptodornase were detected in bovine GCS isolates (72%) 
but not in the human GCS/GGS isolates. All these genes were shown to be expressed by RT-
PCR. Phylogenetic analysis of superantigen gene sequences revealed a high level (>98%) of 
identity among genes of the bovine GCS, of the horse pathogen Streptococcus equi subsp. equi, 
and of the human pathogen GAS. These findings suggest that GAS phages may putatively play 
a role in the bovine GCS evolution. S. pyogenes virulence determinants located in non-
bacteriophage-related mobile elements, such as the gene encoding R28 (an adhesin) and the 
composite transposon Tn1207.3/Φ10394.4 were also detected in bovine GCS (100%). 
In addition, S. pyogenes streptolysin S gene (sagA), strongly associated with invasive disease in 
humans, was detected in the two S. dysgalactiae subsp. dysgalactiae invasive strains. 
The bovine streptococci were susceptible to clinical relevant antimicrobials (namely penicillin, 
cefoperazone and cefazolin); however resistance levels against erythromycin and pirlimycin 
were high when compared with data from other countries. Co-resistance to macrolide and 
lincosamide antimicrobials (corresponding to the cMLSB phenotype) was detected in 21% of 
isolates and associated with the presence of ermB or ermA genes. All pirlimycin-resistant and 
erythromycin-susceptible isolates (L-phenotype; n=11) carry the linB gene known to be 
acquired via a transferable plasmid of Enterococcus faecium. Resistance to tetracycline was 
high (>60% of total isolates) despite it’s no longer use for treating bovine infections, and 
associated with the presence of tetracycline resistance determinants tetO, tetM, tetK, and/or tetS. 
 In conclusion, the presence of relevant GAS virulence genes in S. dysgalactiae subsp. 
dysgalactiae may contribute to the increased virulence potential of these strains, and thus, S. 
dysgalactiae subsp. dysgalactiae (considered a strictly-animal pathogen) should not be 
disregarded as a possible human pathogen. Our results also underline the importance of locally 
monitoring antimicrobial resistance for improvement of antibiotherapy programmes. 
 
 
Keywords: Streptococcus agalactiae; Streptococcus dysgalactiae subsp. dysgalactiae; 
Streptococcus uberis; Molecular typing; Antimicrobial resistance; Virulence. 
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 Septococcus agalactiae (Streptococcus do Grupo B - GBS), Streptococcus dysgalactiae 
subsp. dysgalactiae (Streptococcus do Grupo C - GCS) e Streptococcus uberis são agentes 
patogénicos relevantes associados a mastite de bovinos, a patologia de maior impacto 
económico na indústria de lacticínios devido à utilização de antimicrobianos (utilizados em 
terapia para curar esta doença) e diminuição da produção de leite. No entanto, a caracterização 
de isolados pertencentes a Streptococcus spp. responsáveis por mastite bovina em explorações 
Portuguesas não era conhecida até à elaboração deste trabalho, o que é fundamental para o 
melhoramento de programas de terapêutica e controlo desta doença. O presente trabalho visou 
identificar as características moleculares e perfis de resistência a antimicrobianos de estirpes 
GBS (n=60), GCS (n=18) e S. uberis (n=30) causadoras de mastite subclinica de bovinos, 
recolhidas entre 2002-2003 em Portugal. Adicionalmente, duas estirpes de S. dysgalactiae 
subsp. dysgalactiae associadas a doença invasiva (uma recolhida de um bovino e a outra de um 
humano), e seis estirpes de S. dysgalactiae subsp. equisimilis (Streptococcus do Grupo C ou G - 
GCS/GGS) de infecção em humanos, foram incluídas neste estudo para efeitos comparativos. 
 A genotipagem foi realizada utilizando electroforese de campo pulsado 
(PFGE)/BioNumerics, sequenciação de múltiplos loci (MLST), serotipagem molecular de S. 
agalactiae, amplificação por PCR para rastrear presença de determinados genes, e subsequente 
sequenciação de genes específicos para efectuar análise filogenética, transcritase reversa (RT-
PCR) para análise da expressão genética, e utilização de um microarray contendo 220 genes de 
virulência do agente patogénico de humanos Streptococcus pyogenes (Streptococcus do Grupo 
A - GAS) para testar as estirpes GCS bovinas e as estirpes GCS/GGS humanas. O perfil de 
resistência a antimicrobianos foi avaliado através do método de difusão em disco aos fármacos: 
penicilina, gentamicina, estreptomicina, amoxicilina-ácido clavulânico, cefazolina, 
cefoperazona, rifaximina, eritromicina, pirlimicina, tetraciclina, vancomicina, cloranfenicol, e 
análise de fenótipos de resistência aos macrólidos e lincosamidas (cMLSB, iMLSB, M, e L). 
 Por PFGE, observou-se que em S. uberis três grupos clonais (definidos >80% em 
dendrogramas) incluíam 47% dos isolados, e em S. agalactiae quatro grandes grupos clonais 
incluíam 50% dos isolados (todos associados à mesma exploração), o que é indicativo de 
transmissão directa entre animais. Observaram-se perfis de PFGE idênticos (100% de 
semelhança) entre isolados de S. dysgalactiae subsp. dysgalactiae provenientes de explorações 
de bovinos distintas o que sugere uma fonte ambiental para este agente patogénico. Por MLST, 
verificou-se que todos os perfis alélicos (ST) encontrados em S. uberis são novos (n=14), o que 
representa novas estruturas genómicas em S. uberis. Em GBS apenas 3 linhagens (ST-2, ST-23 
e ST-61/ST-554) foram identificadas o que indica pouca heterogeneidade na colecção de GBS. 
Novas sequências cpsD-cpsE-cpsF do locus cps (que codifica o polissacarídeo capsular) foram 
identificadas em >70% dos isolados GBS, as quais podem representar novos serótipos. 
Resumo
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Observou-se a presença de sequências de inserção (anteriormente descritas em GBS de 
humanos) no gene cpsE do locus cps em quatro estirpes de GBS bovinas (7%). Estas inserções 
provavelmente impedem a expressão do polissacarídeo capsular nestas estirpes. 
Isolados de GBS bovinos (>20%) contêm os genes de virulência lmb e scpB (que codificam a 
proteina laminin-binding e a C5a peptidase, respectivamente), factores considerados necessários 
para estirpes GBS de humanos infectarem o hospedeiro humano. Os restantes isolados poderão 
ter perdido a região que inclui os genes lmb-scpB durante a adaptação ao hospedeiro bovino. 
Genes associados a genomas fágicos de GAS (speC, speM, speK, speL, spd1, sdn) que 
codificam superantigénios, DNase, e estreptodornase foram detectados nos isolados bovinos 
GCS (72%) mas não nos isolados GCS/GGS de humanos. Verificou-se por RT-PCR que estes 
genes são expressos. Através de análise filogenética das sequencias dos genes que codificam 
superantigénios verificou-se elevado nível (>98%) de identidade entre os genes dos isolados 
bovinos GCS, do agente patogénico de cavalos Streptococcus equi subsp. equi, e do agente 
patogénico de humanos GAS. Estes resultados sugerem que os fagos de GAS contribuem para a 
evolução de GCS de bovinos. Determinantes de virulência de GAS localizados em elementos 
genéticos móveis (de origem não-fágica) como o gene que codifica a proteína R28 (adesina) e o 
transposão composto Tn1207.3/Φ10394.4 foram detectados nos isolados bovinos GCS (100%). 
Além disso, o gene sagA (que codifica para a estreptolisina S) de S. pyogenes, associado a 
doença invasiva, foi detectado nas duas estirpes S. dysgalactiae subsp. dysgalactiae invasivas. 
Os isolados bovinos são susceptíveis aos antimicrobianos clinicamente relevantes (penicilina, 
cefazolina, cefoperazona), no entanto observou-se perfis de resistência elevados à eritromicina e 
pirlimicina quando comparados com resultados de outros Países. A resistência à eritromicina e 
pirlimicina (fenótipo cMLSB) em 21% dos isolados deveu-se à presença dos genes ermB/ermA. 
Os isolados resistentes à pirlimicina e susceptíveis à eritromicina (fenótipo L; n=11) possuem o 
gene linB que se sabe ser adquirido via um plasmídeo de Enterococcus faecium. A resistência à 
tetraciclina verificou-se elevada (>60%) e associada à presença dos genes tetO, tetM, tetK, tetS. 
 Em conclusão, a presença de genes de virulência de GAS em S. dysgalactiae subsp. 
dysgalactiae poderá contribuir para o aumento da virulência nestas estirpes, sugerindo que S. 
dysgalactiae subsp. dysgalactiae (considerado agente patogénico exclusivamente de animais) 
não deveria ser desconsiderado como possível agente patogénico em humanos. Salienta-se ainda 
que os programas de terapêutica devem ser definidos de acordo com os perfis de resistência a 
antimicrobianos determinados localmente, e não extrapolando resultados de outros locais. 
 
 
Palavras-chave: Streptococcus agalactiae; Streptococcus dysgalactiae subsp. dysgalactiae; 
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This Ph.D. Thesis is organized in six chapters. It includes three published manuscripts and one 
submitted manuscript. 
 
Chapter 1 provides a general introduction, in particular, it is focused a brief description of the 
genus, the clinical relevance and host range of the streptococcal species under study, a 
description of the reported cases of bovine mastitis in Portugal and a state-of-the-art concerning 
the molecular epidemiology of strains of these bovine species. 
 
Chapter 2 is entitled “Molecular epidemiology and population structure of bovine Streptococcus 
uberis” and includes a published manuscript. This Chapter provides a background knowledge 
and the experimental work focused the molecular epidemiology and population structure of S. 
uberis from Portugal. 
 
Chapter 3 is entitled “Human group A streptococci virulence genes in bovine group C 
streptococci” and includes a published manuscript. This chapter gives a background about the 
virulence traits of the bovine GCS, phage genes of S.pyogenes and implication of GAS phages 
in other human streptococci and in bovine GCS. The experimental work was focused in the 
search of virulence traits of the human S. pyogenes in mastitis GCS isolates. 
 
Chapter 4 is entitled “Virulence gene pool detected in bovine group C S. dysgalactiae subsp. 
dysgalactiae isolates by use of a group A S. pyogenes virulence microarray” and includes a 
published manuscript. This Chapter provides a background about the most recent panorama of 
the pathogenesis of S. dysgalactiae subsp. dysgalactiae associated with invasive disease. The 
experimental work comprised the comparison of bovine Streptococcus dysgalactiae subsp. 
dysgalactiae and the human GAS, and S. dysgalactiae subsp. equisimilis using an array of 
virulence genes from S. pyogenes.  
 
Chapter 5 is entitled “Antimicrobial resistance traits and molecular epidemiology of 
streptococci from bovine mastitis” and consists of one submitted manuscript with modifications. 
This chapter provides background knowledge in antimicrobial resistance, molecular 
epidemiology and population structure among streptococci associated with mastitis. The 
experimental work focused in the comparative antimicrobial resistance genotyping and the 
molecular epidemiology of the three species, S. agalactiae, S. dysgalactiae subsp. dysgalactiae 
and S. uberis, and, a more detailed characterization of S. agalactiae by virulence genotyping and 
molecular serotyping. 
Outline of the thesis
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Finally, Chapter 6 provides the conclusions and an outlook for future research in a same topic as 
presented in Chapter 4. 
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Chapter 1  
1.1. The genus Streptococcus spp. 
 
1.1.1. Brief description of taxonomy and historical perspective  
 
The genus Streptococcus comprises numerous clinically significant species which are 
responsible for wide variety of infections in human and animals. Structurally, streptococci are 
Gram-positive, non-motile, non-sporeforming, catalase-negative cocci, which due to single and 
parallel division plan form chains composed of two or more cells (Fig.1.1). 
Most streptococci are facultative anaerobes, and some are obligate (strict) anaerobes. Some 
require blood supplemented agar for in vitro growth, which is often used to observe phenotypic 
differences among streptococci species (Facklam et al. 2002), (see below). 
 
 
 
 
 
 
 
 
 
 
 
Colony morphology, hemolysis on blood agar plates, biochemical reactions, and serologic 
specificity consist in phenotypic characteristics of streptococci which are used for their 
classification and identification (Wyder et al., 2011). 
Streptococci are divided into three groups based on their type of hemolysis reaction on blood 
agar plates (Fig. 1.2): beta-hemolysis consisting in complete lysis of red blood cells (clear halo 
around the colonies); alpha-hemolysis consisting in incomplete lysis of red blood cells (green 
color halo around the colonies); and no lysis of red blood cells (no hemolysis is observed 
around the colonies). Streptococcus agalactiae, or the Group B Streptococcus (GBS), can be 
presumably identified by the CAMP test, a technique also based on the hemolytic reaction 
observed in blood agar plates (see Fig. 1.3). 
Rapid commercial systems, in particular the API 20 STREP® (BioMérieux, Marcy l’Etoile, 
France) involving a series of miniaturized biochemical tests, are also used for streptococci 
identification (Wyder et al., 2011). 
Figure 1.1. Morphology of the streptococci. Streptococci divide in a single plane and tend not to separate, 
causing chain formation (adapted from Patterson, 1996). 
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Serologic grouping for identification of streptococci is based on antigenic differences in cell 
wall carbohydrate composition, in the cell wall pili-associated protein, and in the polysaccharide 
capsule (Fischetti, 2000; Mora et al., 2005; Kong et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Rebecca Lancefield (1933) systematized the classification of streptococci based on their type of 
surface antigen, which is a standard technique still used nowadays based in agglutination tests 
and labelling using capital letters: the Lancefield serological grouping (see Fig. 1.4). 
Nomenclature for streptococci in particular in medical use has been largely based on the 
identification of cell wall components rather than on species names (e.g., Streptococcus 
agalactiae is commonly referred to as group B Streptococcus or GBS, and Streptococcus 
Figure 1.3. The CAMP test for presumably identification of Streptococcus agalactiae or group B 
streptococci (GBS) consists on visible hemolysis on blood agar media (arrow shaped) that occurs when 
diffusible extracellular CAMP factor of Streptococcus agalactiae (streak A), reacts with β-hemolysin of 
Staphyloccocus aureus ATCC® 25923 (streak B). Negative result for Streptococcus uberis (streak C). 
(Photo: Márcia G. Rato, FCT/UNL) 
A
B
C
Figure 1.2. Hemolysis reaction of streptococci on blood agar plates: A) beta-hemolysis; B) alpha-
hemolysis; C) no hemolysis. Agar plates were supplemented with 5% sheep blood. 
(Photos: Márcia G. Rato, FCT/UNL) 
A: Streptococcus agalactiae B: Streptococcus dysgalactiae 
subsp. dysgalactiae 
 
C: Streptococcus uberis 
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pyogenes is often referred to as group A Streptococcus or GAS) (Fischetti, 2008; Fischetti, 
2000). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
The first description of streptococcus is though to have been made by Louis Pasteur in 1879 
which described them as “chains of beads”. The generic name “Streptococcus” of the genus was 
first proposed by Rosenbach in 1884, and the earliest attempt to differentiate streptococci is 
thought to have been made by Shottmuller in 1903 by using blood agar plates (Evans, 1936; 
Facklam, 2002). 
Nomenclature and taxonomic revisions have been performed in Streptococcus genus in the last 
decades. In the mid-1980s, the genus Streptococcus was split into three different genera: 
Enterococcus, Lactococcus and Streptococcus (Schleifer & Kilpper-Balz, 1984; Schleifer & 
Kilpper-Balz, 1987). Later, in 1995 the streptococci genus was divided into six different 
divisions (pyogenic, anginosus, mitis, mutans, salivarius, and bovis) based on their 16S rRNA 
gene sequence analysis (Kawamura et al., 1995), (see Fig. 1.5). 
Particularly, in the late 1990s, the genotypic and phenotypic characterization of S. dysgalactiae 
strains from different sources (human and animal) revealed the existence of two subpopulations 
of strains within the S. dysgalactiae species (Vandamme et al., 1996; Vieira et al., 1998). Thus 
the term S. dysgalactiae subsp. dysgalactiae was proposed for the group of strains from animal 
origin (mostly associated with bovine mastitis) belonging to Lancefield group C, alpha-
hemolytic or nonhemolytic, and which did not exhibit streptokinase activity on human 
Figure 1.4. Specific carbohydrates are found in different Streptococcus species: A) schematic 
representation of streptococcal cell covered with an outer hyaluronic acid capsule and the group 
carbohydrate; B) photo showing a commercial slide agglutination test (Slidex® Strepto Kit, BioMérieux, 
Marcy l’Etoile, France) for identification of Lancefield A, B, C, F and G group antigens from colonies, 
based on co-agglutination of the group-specific antigen and the corresponding antibody. Here is shown 
Streptococcus dysgalactiae subsp. dysgalactiae belonging to Lancefield group C. 
(Photo: Márcia G. Rato, FCT/UNL). 
A 
B 
Group C 
Group G Group F 
Group B Group A 
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plasminogen (Vieira et al., 1998). The name S. dysgalactiae subsp. equisimilis was proposed for 
the group of S. dysgalactiae strains (from human and animals) which belonged to Lancefield C, 
G and L, groups, beta-hemolytic and exhibiting streptokinase activity on human plasminogen 
(Vandamme et al., 1996; Vieira et al., 1998). 
 
 
 
 
 
 
 
 A  
 
 
 
 
 
 
 
 
 
 
Some streptococcal species, namely Streptococcus pneumoniae and Streptococcus uberis do not 
possess defined group antigens and thus cannot be classified by the Lancefield serogrouping 
system, a standardized method for the identification of streptococci, as mentioned above 
(Facklam, 2002). Non-hemolytic and alpha-hemolytic strains (variants) have been previously 
reported among human S. pyogenes and S. dysgalactiae subsp. equisimilis strains, which are 
beta-hemolytic (Dierksen & Tagg, 2000; Woo et al., 2003). These variants may putatively be 
misidentified in case the identification is primarly based in hemolysis type of colonies on blood 
agar plates (Dierksen & Tagg, 2000; Woo et al., 2003). 
For these reasons, molecular techniques are currently used in addition to phenotypic techniques, 
to complement Streptococcus spp. identification, namely the 16S–23S rRNA interspacer region 
analysis (Chen et al., 2004), sequencing of the manganese-dependent superoxide dismutase 
gene (sodA) (Abdelsalam et al., 2010) and inner features of 16S rRNA gene analysis (Lal et al., 
2011). These techniques are based in the analysis of molecular sequences that are generally 
more revealing of evolutionary relationships than is classical techniques based in phenotypic 
characteristics (Woese et al., 1990; Wyder et al., 2011). 
Figure 1.5. Phylogenetic relationships of 34 Streptococcus species based on their 16S rRNA gene 
sequences (Kawamura et al., 1995). 
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1.1.2. Clinical relevance and host range 
 
Various streptococcal species are involved in colonization of human and other mammals and 
can cause disease. For several decades, interest was focused in only two species that caused 
human infection: S. pyogenes (GAS) and S. pneumoniae (pneumococci). However, the 
pathogenic potential for humans of other streptococcal species such as those belonging to 
Lancefield group B, C, or G antigens (GBS, GCS, and GGS), has been documented (Luan et al., 
2005; Eyre et al., 2010). Furtheremore, some streptococcal species are now recognized 
important animal pathogens such as S. uberis (see below). Several phenotypic characteristics of 
clinical relevant streptococci are listed in Table 1.1. 
 
The major human beta-hemolytic pathogens are included in the pyogenic group. The pyogenic 
group includes the following pathogens: Streptococcus pyogenes (group A Streptococcus, 
GAS), Streptococcus agalactiae (group B Streptococcus, GBS), Streptococcus dysgalactiae 
subsp. dysgalactiae (group C Streptococcus, GCS), Streptococcus dysgalactiae subsp. 
equisimilis (group G, C, and rarely, group L and group A Streptococcus), Streptococcus equi 
subsp. equi (GCS), Streptococcus equi subsp. zooepidemicus (GCS) and Streptococcus uberis. 
S. pyogenes (GAS) is a strictly-human pathogen and causes a variety of diseases such as 
pharyngitis, skin and soft tissue infection, impetigo (considered superficial diseases), 
bacteraemia, necrotizing fasciitis, deep soft tissue infections, cellulitis, pneumonia (considered 
deep infections), toxic shock-like syndrome, scarletina (toxin mediated diseases), rheumatic 
fever and post-streptococcal glomerulonephritis (immunologically mediated diseases) 
(Efstratiou, 2000). 
S. agalactiae (GBS) is considered nowadays the leading cause of septicemia and meningitis in 
human newborn infants and pregnant woman, and associated with bovine mastitis (Liu & Nizet, 
2004; Rajagopal, 2009; Barkema et al., 2009). Furthermore, GBS has been isolated from dogs, 
cats, goats and non-mammals such as fish, frogs and crocodiles (Bishop et al., 2007). 
S. dysgalactiae subsp equisimilis (GCS/GGS) is a commensal organism, and causes a spectrum 
of diseases in humans that resemble GAS infections, which include streptococcal toxic shock 
syndrome, severe soft tissue infection and poststreptococcal sequelae (Efstratiou, 1997; 
Takahashi et al., 2011). S. dysgalactiae subsp equisimilis is also a cause of septicaemia, arthritis 
and valvular endocarditis in pigs, and lymphadenitis and placentitis in horses (Kawata et al., 
2003; Timoney, 2004). 
Streptococcus dysgalactiae subsp. dysgalactiae (GCS) is considered to be associated only with 
animal infections, mostly bovine mastitis (Facklam, 2002). Nevertheless, it has been recently 
reported associated with severe invasive disease in dogs, bovine, ovine, fish, and in a human in 
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Table 1.1. Phenotypic characteristics of β-hemolytic streptococcib (adapted from Facklam, 2002) 
contact (skin puncture) with raw fish (Vela et al., 2006; Chénier et al., 2008; Lacasta et al., 
2008; Koh et al., 2009). 
 
 
 
 
 
 
 
 
 
 
 
Species Lancefield Bac PYR Cam VP Hip Arg Esc Str Sbl Tre Rib Origin 
S. pyogenes A + + - - - + v - - NA - Human 
S. agalactiae B - - + - + + - - - NA NA 
Human, 
bovine 
S. dysgalactiae   
subsp. 
dysgalactiaeb 
C - - - - - + v - v + + Animals 
S. dysgalactiae    
subsp. 
equisimilisc 
A, C, G, L - - - - - + + - - + + 
Human, 
animals 
S. equi  subsp. 
equi 
C - - - - - + v + - - NA Animals 
S. equi subsp.  
zooepidemicus 
C - - - - - + v + + v NA 
Animals, 
human,  
S. canisc G - - + - - + + - - v NA 
Dog, 
human 
S. anginosus 
(group)d 
A, C, G, F, 
none 
- - - + - + + - - + NA Human 
S. porcinus 
E, P, U, V, 
none, new 
- + + + v + + - + + NA 
Swine, 
human 
S. iniae None - + + - - - + + - NA NA 
Dolphin, 
fish, 
human 
S. phocae C, F + - - - - - - - - NA NA Seal 
S. didelphis None - - - - - + - - - + NA Opossum 
Abbreviations: Group, group carbohydrate antigen; Bac, bacitracin; Pyr, pyrrolidonylarylamidase; Cam, 
CAMP reaction; VP, Voges-Proskauer reaction; Hip, hydrolysis of hippurate; Arg, deamination of 
arginine; Esc, hydrolysis of esculin; Str, hydrolysis of starch; Sbl, Tre, and Rib, production of acid in 
sorbitol, trehalose, and ribose broth, respectively. +, positive reaction (>95%); -, negative reaction 
(>95%); v, variable reaction (6 to 94% positive); NA, not applicable. 
b S. dysgalactiae subsp. dysgalactiae strains are not beta-hemolytic (are alpha-hemolytic) but were 
included in the Table. 
c To differentiate between the group G S. canis and group G S. dysgalactiae subsp. equisimilis, testing of 
α-galactosidase, β-galactosidase, and β-glucoronidase needs to be performed. S. canis is positive for α- 
and β-galactosidase and negative for β-glucoronidase; S. dysgalactiae subsp. equisimilis gives the 
opposite reactions. 
d The S. anginosus group includes beta-hemolytic strains of S. anginosus, S. constellatus, and S. 
intermedius. There are insufficient data to know the percentage of each of these beta-hemolytic species 
that contain carbohydrate antigens. 
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Streptococcus equi subsp. equi (GCS) is a horse-restricted pathogen, and considered to have 
evolved from Streptococcus equi subsp. zooepidemicus (GCS), a zoonotic pathogen (Holden et 
al., 2009). Streptococcus equi subsp. equi is the causative agent of equine strangles, and 
Streptococcus equi subsp. zooepidemicus is associated with respiratory disease and metritis in 
horses, respiratory diseases such as pneumonia in dogs, and bacteraemia, endocarditis, 
meningitis, nephritis, and post-streptococcal glomerulonephritis in humans (Nicholson et al., 
2000; Timoney, 2004; Beres et al., 2008; Priestnall et al., 2010). 
Streptococcus uberis, as far as we know, has never been reported associated with human 
infections, and is a recognized pathogen associated with bovine mastitis (Ward et al., 2009). 
 
The mitis group/division comprises streptococcal species of which almost all are isolated from 
the human oral cavity or nasopharynx: Streptococcus oralis, S. mitis, S. gordonii, and S. 
pneumoniae. The latter (S. pneumoniae) is associated with otitis media, bronchitis, sinusitis, 
pneumonia, invasive disease, and meningitis in humans (Kadioglu et al., 2008; Mook-Kanamori 
et al., 2011). S. pneumoniae is also associated with respiratory insufficiency in horses and 
meningitis in gerbils and monkeys (Muffat-Jolly et al., 1994; Graczyk et al., 1995; Timoney, 
2004). 
The anginosus and salivarius divisions contain mainly streptococci from the oral cavity from 
human and animal origin, and the bovis group contains streptococci from human equine and 
bovine origin (Facklam, 2002). The mutans group, which is the most distant related 
streptococcal group (Fig. 1.5), includes streptococci from the oral cavities associated with the 
development of dental caries among humans and other mammals, namely hamsters, rats and 
monkeys (Facklam, 2002). 
 
1.2. Bovine mastitis 
 
Mastitis is an inflammation of the bovine udder, usually as a consequence of bacterial invasion 
of the mammary gland (Viguier et al., 2009). These pathogens cause injury to milk secreting 
tissue and various ducts throughout the mammary gland (Almeida & Oliver, 1995; Tamilselvam 
et al., 2006). Leukocytes or somatic cells present in the milk are used to define milk quality. 
Elevated somatic cells in milk, in consequence of mastitis, alter milk composition which 
undervalues milk, and cause a reduction of milk production (Gröhn et al., 2004; Zadoks et al., 
2004). 
Clinical mastitis is easily detectable and characterized by abnormal milk production and 
swelling or pain in the bovine udder, and may be accompanied by other systemic signs (Viguier 
et al., 2009). Subclinical mastitis is characterized by no noticeable changes in the appearance of 
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the milk or the udder, but bacteria may be present in the secretion and the composition of milk 
is altered in terms of rise of somatic cells, and milk production decreases (Viguier et al., 2009).  
Despite the ongoing efforts for the prevention of this disease since the “five point plan” was 
established (in the 1960s), bovine mastitis remains the most important disease in the dairy 
industry because of economic loss due to treatment costs (antibiotherapy), and loss in milk 
production and quality (Neave et al., 1966; Bradley, 2002; Seegers et al., 2003; Erskine et al., 
2003; Zadoks et al., 2004; LeBlanc et al. 2006; Viguier et al., 2009). 
 
Studying microbial aetiology of mastitis and evaluating antimicrobial resistance patterns has 
become crucial to better control this disease (Erskine et al., 2003; White et al., 2006; Muellner 
et al., 2011). As far as we know, few studies regarding microbial aetiology of bovine mastitis in 
Portugal have been reported. In the central region of Portugal, a survey has been conducted 
among 12 farms from February 2002 to May 2003, involving 459 milk samples collected from 
bovines with subclinical mastitis (Bexiga et al., 2005). No significant differences in the 
frequency of the pathogens were found when compared to a previous study performed in the 
same geographical area 20 years earlier (Atalaia, 1983; Bexiga et al., 2005). Both studies 
reported a higher frequency of “contagious” pathogens (i.e. S. agalactiae and Staphylococcus 
aureus) when compared to “environmental” pathogens (i.e. S. uberis and Escherichia coli). 
In contrast, in other countries (where microbial aetiology of bovine mastitis is extensively 
studied) a major shift in the frequency of udder pathogens was reported in the last years 
(Bradley, 2002; Pitkälä et al., 2004; Pullinger et al., 2007; Shum et al., 2009; Breen et al., 
2009). These studies point out that when control measures in herds are effectively implemented, 
the contagious pathogens (S. agalactiae and S. aureus) are under control in farms, while 
environmental pathogens (S. uberis and E. coli) are increasing in frequency and difficult to 
eradicate (Bradley, 2002; Pitkälä et al., 2004; Pullinger et al., 2007; Shum et al., 2009; Breen et 
al., 2009). S. uberis, in particular, considered an “environmental” pathogen, has become 
nowadays a major problem in herds where control measures are efficiently implemented 
(Lopez-Benavides et al. 2007). 
 
1.3. Streptococci associated with bovine mastitis 
 
S. uberis is traditionally considered an environmental pathogen because it may be found and 
acquired in the bovine surroundings, such as straw or peat used in bedding materials, in farm 
soil, nose, vagina, and rumen of the bovines (Zadoks et al., 2005[a]; Lopez-Benavides et al., 
2007; Ericsson et al., 2009). On the other hand, S. agalactiae is considered a contagious 
pathogen because it is spread from infected to healthy udders, between quarters of the same 
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animal and between animals (e.g., through the milking machine) and is not found in the 
environment of the bovine (Barkema et al., 2009). S. dysgalactiae subsp. dysgalactiae is 
considered either an environmental or contagious pathogen (Ericsson et al., 2009). 
 
1.3.1. Population structure and evolution of genomes and its implication in 
pathogenesis 
 
1.3.1.1. Streptococcus agalactiae 
 
Complete genome sequences were obtained for three invasive S. agalactiae strains from human 
origin, and draft sequences have been obtained for another five S.agalactiae strains from human 
origin (COH1, 515, CJB111, H36B, 18RS21) and one S.agalactiae strain from bovine mastitis 
(FSL S3-026), (Tettelin et al., 2002; Glaser et al., 2002; Richards et al., 2011), (see Table 1.2). 
 
 
 
 
 
 
Virulence factors that have been documented among human S. agalactiae isolates include the 
polysaccharide capsule, the Alp family of proteins, the C5a peptidase, the Lmb protein, 
fibrinogen-binding FbsA, FbsB, and Spb1, secreted hemolysin, and superoxide dismutase 
(Franken et al., 2001; Liu & Nizet, 2004; Lindahl et al., 2005; Rajagopal, 2009). Few of these 
virulence determinants have also been described among bovine GBS isolates (Brochet et al., 
2006). However, bovine S. agalactiae isolates are not so extensively studied. 
 
Species and strain ID Origin Serot. Length of the 
genome (nt) 
G+C 
content (%) 
Accession 
number 
Reference 
Streptococcus 
agalactiae 2603V/R 
human V 2160267 35 NC_004116 
Tettelin et al., 
2002 
Streptococcus 
agalactiae NEM316 
human III 2211485 35 NC_004368 
Glaser et al., 
2002 
Streptococcus 
agalactiae A909 
human Ia 2127839 35 NC_007432 
Tettelin et al., 
2005 
Streptococcus uberis 
0140J 
bovine NA  1852352 36 NC_012004 
Ward et al., 
2009 
*Draft sequences have also been obtained for another five S.agalactiae strains from human origin (COH1, 515, 
CJB111, H36B, 18RS21), one S.agalactiae strain from bovine mastitis (FSL S3-026) and one S. dysgalactiae subsp. 
dysgalactiae  (ATCC 27957) from bovine milk (Tettelin et al, 2005; Richards et al., 2011); Serot., serotype; NA, not 
applicable. Information from the National Center for Biotechnology (NCBI) database (Bethesda, MD, USA).  
Table 1.2. Characteristics of each streptoccal strain for which complete genome sequences was 
obtained* 
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The virulence genes scpB and lmb (encoding C5a peptidase and Lmb protein, respectively) are 
present in all human S. agalactiae strains, but usually absent in the bovine S. agalactiae strains 
(Franken et al., 2001). The scpB-lmb intergenic region is known to be a hotspot for the 
integration of the mobile genetic elements IS1548 and GBSi1, previously described in human 
GBS belonging to clonal complex 19 (CC19) and CC17, respectively, as assessed by MLST 
(Safadi et al., 2010). Not much is known regarding the distribution (or absence) of these mobile 
genetic elements in the few bovine GBS that carry the above mentioned genes. 
 
GBS may be serotyped based on their capsular polysaccharides antigens (as previously 
mentioned). The predominant serotypes in GBS isolates from human origin are Ia, III, and Ib, II 
and V (Ippolito et al., 2010; Tien et al., 2011). In contrast, GBS isolates from bovine origin are 
not serotyped frequently by the conventional serotyping method (based on agglutination with 
specific serum and labelled with Ia to IX), because they possess antigens which are distinct than 
those recognized among human isolates. Also, few reports have described so far, bovine GBS 
isolates studied by molecular serotyping (Kong et al., 2002; Zhao et al., 2007). 
Population structure of GBS isolates from bovine origin is much less described than GBS 
isolates from human origin. Most bovine GBS, described so far, belong to sequence type 61 
(ST-61), ST-2 and ST-23, or are new (Bisharat et al., 2004; Brochet et al., 2006). 
Human S. agalactiae strains belonging to clonal complex 17 (CC17) are strongly associated 
with invasive disease of the central nervous system of neonates, and divergent opinions coexist 
as to a possible emergence of this highly virulent human lineage (CC17) from a bovine lineage - 
CC61 (Bisharat et al., 2004; Luan et al., 2005; Sørensen et al., 2010). These two lineages 
(CC17 and CC61) are close related as assessed by eBURST analysis (see Fig. 1.6). 
Human GBS isolates which belong to clonal complex 1 (CC1), CC8 or CC23 are very 
homogeneous in terms of their prophage content indicating that transduction mechanisms 
underlining recombination in S. agalactiae may be specific to GBS subpopulations of certain 
lineages (Salloum et al., 2011). 
 
A partial genome sequence of a S. agalactiae strain from bovine mastitis has been recently 
published (Richards et al., 2011). The bovine GBS genome revealed the presence of an unusual 
high frequency of insertion sequences, particularly when compared to human GBS genomes 
known to date, probably in result of the adaptation to the bovine host (Richards et al., 2011). 
 
Bisharat et al. (2004) observed higher homology among a bovine GBS collection of strains than 
among a human GBS collection of strains. The author considered the two populations (bovine 
and human) distinct by using MLST analysis (Bisharat et al., 2004). In contrast, Brochet et al. 
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(2006) observed little distinction between two collections of human and bovine S. agalactiae 
strains by using MLST and microarray analysis. Further studies, in particular of bovine GBS 
isolates, are in need in order to assess if human/bovine GBS represents two subpopulations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3.1.2. Streptococcus uberis 
 
A genome sequence has been obtained for a S. uberis strain (Ward et al., 2009), (Table 1.2). A 
lower number of mobile genetic elements in the genome of S. uberis were described when 
compared with other streptococci from the pyogenic group (Ward et al., 2009). On the other 
hand, a great diversity of genes encoding sugar transport and utilization which provide this 
pathogen to survive in a variety of nutritional habitats has been described, suggesting S. uberis 
as an opportunistic pathogen adapted to changing environmental conditions (Lopez-Benavides 
et al., 2007; Ward et al., 2009). 
S. uberis is often associated with persistent infections in the bovine udder, and several proteins 
involved in metabolic activities, which may be implicated in early colonization of S. uberis 
during the infection process, have been described (Tamilselvam et al., 2006; Ericsson Unnerstad 
CC19 
Figure 1.6. MLST/eBURST diagram showing the relationships between S. agalactiae strains 
(http://eburst.mlst.net/). Red circles indicate CC23, CC2, and CC61 (which include ST that are found 
among bovine GBS). 
554 
CC23 
CC17
CC61/67 
CC2
CC1
CC19 CC8 
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et al., 2009; Chen et al., 2011). S. uberis virulence factors include the hyaluronic acid capsule, 
plasminogen activator proteins PauA and PauB, the adherence and internalization into epithelial 
cells mediated by SUAM, and glyceraldehide-3-phosphate dehydrogenase (Rosey et al., 1999; 
Ward et al., 2001; Ward & Leigh, 2002; Chen et al., 2011; Reinoso et al., 2011). Recently, the 
ISS1-like insertion sequence found in S. uberis genome was suggested to have a role in the 
virulence capacity of S. uberis, although further studies are in need to clarify this assumption 
(Dego et al., 2011). 
The genetic profiles available in the S. uberis MLST database include sequence types (ST) from 
isolates collected mostly in United Kingdom, Australia, Sweden and Denmark 
(http://pubmlst.org/suberis/; Pullinger et al., 2006). However, information regarding population 
structure of S. uberis in Southern European countries has not been described as far as we know. 
In particular, population structure among S. uberis isolates collected from farms in Portugal was 
unknown before the present work. 
 
1.3.1.3. Streptococcus dysgalactiae subsp. dysgalactiae 
 
S. dysgalactiae subsp. dysgalactiae (GCS) virulence factors include M-like proteins, which are 
responsible for the interaction of this pathogen with extracellular matrix proteins of bovine 
epithelium from the mammary gland (Vasi et al., 2000). Indeed, S. dysgalactiae subsp. 
dysgalactiae is known to persist inside the bovine mammary epithelial cells (Almeida & Oliver, 
1995; Calvinho et al., 1998). Recently, this pathogen has been reported associated with invasive 
disease in a diverse range of hosts, including the human host (koh et al.., 2009). However, 
presence of genes usually associated with invasive disease among S. dysgalactiae subsp. 
dysgalactiae isolates was not described before, with exception of sagA gene (Chénier et al., 
2008; Abdelsalam et al., 2010). 
On the other hand, S. dysgalactiae subsp. equisimilis (GCS, GGS) has been reported associated 
with human diseases that coincide with the diseases described for the human pathogen S. 
pyogenes, which shares the same host niche in humans. Indeed, S. dysgalactiae subsp. 
equisimilis and S. pyogenes have the same virulence factors, namely the M-protein, C5a 
peptidase, and streptokinase (Fischetti, 2000; Geyer & Schmidt, 2000). Furthermore, cross-
species acquisition of phage-associated virulence genes, namely speM, ssa, or smeZ (strongly 
associated with invasive disease) between S. pyogenes and S. dysgalactiae subsp. equisimilis are 
known to occur (Igwe et al., 2003; Davies et al., 2005). However, genomic contributions of the 
human S. pyogenes to the bovine group C S. dysgalactiae subsp. dysgalactiae (GCS) genome 
were unknown before the present work. 
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The complete genome sequencing of several S. pyogenes (GAS) strains has revealed the 
presence of lysogenic bacteriophages in GAS genomes (Beres & Musser, 2007), (see Fig. 1.7). 
In fact, numerous virulence characteristics in this pathogen are phage associated (Beres & 
Musser, 2007). S. pyogenes phages are members of the Siphoviridae family of bacteriophages 
(Canchaya et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7. Representation of Streptococcus pyogenes exogenous elements among 12 Streptococcus 
pyogenes sequenced genomes (Beres & Musser, 2007). Illustrated are the loci of integration of phages and 
integrative conjugative elements (ICEs) into the core chromosome. Prophages are indicated with triangles 
and ICEs with squares. Stacked triangles and squares indicate a common integration site. Elements are 
colour-coded to indicate the source strain.  Prophages and ICEs are numbered as they occur clockwise 
around the core chromosome for each strain. Integration loci are lettered alphabetically as they occur 
clockwise around the core chromosome. Gene designations are as follows: 1) secreted pyrogenic-toxin-
superantigens: speA, speC, speH, speI, speK, speL, speM, and ssa; 2) secreted DNAses: sda, sdn, spd1, 
spd3, and spd4; 3) secreted phospholipase: sla; 4) antimicrobial resistance: ermA, mefA, and tetO; 5) cell 
surface adhesins: R6 and R28; 6) none, these elements lack a known or obvious virulence gene. 
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A complete structure of a group G S. dysgalactiae subsp. equisimilis phage (Φ3396) has been 
sequenced (Davies et al., 2007). The GGS Φ3396 phage shared overall genomic identity with 
the S. pyogenes 315.1 phage family, but exhibited evidence of recombination from other 
streptococcal phages (Davies et al., 2007). 
Also, comparative genomic analysis between S. dysgalactiae subsp. equisimilis and S. 
dysgalactiae subsp. dysgalactiae revealed that some of the differences in the virulence gene 
repertoire between these two pathogens could be ascribed to prophage and integrative 
conjugative elements (Suzuki et al., 2011). 
Genomic comparisons between S. dysgalactiae subsp. dysgalactiae, S. dysgalactiae subsp. 
equisimilis and S. pyogenes, are likely to provide further information regarding cross-species 
acquisition of virulence genes that may be involved in the adaptation to new host. 
 
1.3.2. Molecular typing 
 
Molecular epidemiology offers unique opportunities to advance the study of diseases through 
the investigation of infectious agents at the molecular level. Molecular tools are becoming more 
widely available to epidemiologists and offer opportunities to increase our understanding of the 
epidemiology of important pathogens affecting human and animal health (Muellner et al., 
2011). 
Multiple-locus variant-repeat assay (MLVA), multilocus sequence typing (MLST), and Pulsed-
Field Gel Electrophoresis (PFGE) are some of the genotyping techniques currently in use for 
typing and distinguish strains among the streptococcal species under study (Radtke et al., 2010; 
http://www.mlst.net/). 
PFGE is generally considered the most discriminatory method to infer relationships between 
strains (Baseggio et al., 1997; Wang et al., 1999; Douglas et al., 2000). Briefly, PFGE is based 
on enzymatic DNA restriction of bacterial genome (by using rare-cutting restriction 
endonucleases) to generate DNA fragments, which are subsequently separated on a gel by 
applying a specific voltage that is periodically switched among different directions in order to 
separate the large DNA fragments. The banding pattern obtained from each isolate is then 
compared with the remaining patterns in order to infer epidemiological relation between the 
isolates. When two isolates show indistinguishable DNA patterns it is assumed that they are a 
same strain, and if the patterns differ then its epidemiological relation must be evaluated 
(Tenover et al., 1995; Van Belkum et al., 2007). 
Different interpretations for analysing of relationships between isolates patterns have been 
described (Zadoks et al., 2002; Van Belkum et al., 2007). 
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MLST allows one to infer evolutionary relationships of strains based on mutations or 
recombination within housekeeping genes, and detects genetic variation that accumulates slowly 
in time (Maiden et al., 1998). MLST is presently one of the reference methods for genotyping S. 
agalactiae and S. uberis (http://pubmlst.org/sagalactiae/, http://pubmlst.org/suberis/). 
MLST allows strain comparison between different laboratories and different countries due to 
public databases which contain the sequence type (ST) information (http://pubmlst.org; Jolley et 
al., 2004). 
 
1.3.3. Antimicrobial resistance 
 
Public health issues in particular those involved with the presence of antimicrobial residues in 
food and dissemination of antimicrobial resistance among bacteria, have determined 
recommendations for a gradual reduction of antimicrobial use in veterinary medicine (WHO, 
2001). The use of antimicrobials in human and veterinary medicine inevitably results in 
selective pressure for drug resistance in exposed bacteria. Guidelines for a rational use of 
antimicrobials in veterinary medicine have been described (WHO, 2001). 
National recommendations regarding decision on which antimicrobial should be chosen as the 
first choice in bovine mastitis treatment exist in certain European countries (Ekman et al., 1994; 
Vaarst et al., 2002). In Portugal, such as in many other countries, due to restraints in time and 
financial considerations this choice is usually performed empirically, based on previous 
experience, national regional recommendations, and also on results obtained by antimicrobial 
resistance studies performed in other countries. However, resistant patterns to antimicrobials are 
known to vary between different countries (Kaspar, 2006; Hendriksen et al, 2008). 
 
The antimicrobials that are presently used for treating bovine mastitis caused by streptococci in 
Portugal include penicillin, ampicillin, cloxacillin, pirlimicyn, cefoperazone and cefquinome 
(http://www.apifarma.pt/simposiumvet/Paginas/Pesquisaavancada.aspx). 
Only rare cases of decreased susceptibility to penicillin among bovine mastitis streptococci have 
been documented (Haenni et al., 2010[b]; Kalmus et al., 2011). Decrease susceptibility to 
cephalosporin antimicrobials (such as cefoperazone and cefquinome) is also rare, and 
cefquinome has been efficiently used for treatment of persistent subclinical mastitis (Tenhagen 
et al., 2006; Kasravi et al., 2011). 
On the contrary, resistance to macrolide antimicrobials is a major concern among not only 
human streptococci but also bovine mastitis streptococci worldwide as previously documented 
(Rossito et al. 2002; Denamiel et al., 2005; Duarte et al., 2005; Botrel et al., 2010). 
Erythromycin (which is a macrolide antimicrobial) in particular, is used as first choice treatment 
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in human therapy in cases where patients are allergic to β-lactam antimicrobials. In some 
countries such as France and the U.S.A., macrolides are used in the treatment of bovine mastitis 
(Zwald et al. 2004; Schmitt-Van de Leemput & Zadoks, 2007; Botrel et al., 2010); but not in 
Portugal (http://www.apifarma.pt/simposiumvet/Paginas/Pesquisaavancada.aspx). 
 
Macrolide (such as erythromycin) and lincosamide (such as pirlimycin) antimicrobials have a 
similar antimicrobial spectra and overlapping targets in their mechanisms of action (see below), 
which justifies monitoring of resistance patterns against both these antimicrobial classes. 
Lincosamide antimicrobials are used in human and animal therapy. Pirlimycin in particular, is 
available for bovine mastitis treatment in Portugal 
(http://www.apifarma.pt/simposiumvet/Paginas/Pesquisaavancada.aspx). 
Due to the implications of resistance to the above mentioned antimicrobials in human and 
animal health, surveillance of resistance among veterinary field isolates is of utmost importance, 
especially in Portugal where such type of information is scarce. 
Evaluation of macrolide phenotypes (M, cMLSB, iMLSB, L) can be performed by using a double 
disk test technique as described previously (Seppälä et al., 1993), (see Fig. 1.8). The MLSB 
phenotype consists in resistance to macrolide, lincosamide, and streptogramin B antimicrobials, 
while the M phenotype consists in resistance to macrolide antimicrobials only. The L phenotype 
consists in resistance to lincosamide antimicrobials (and susceptibility to macrolide). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The genetic determinants ermB and ermA encode methylases that confer resistance to 
erythromycin, and inducible or constitutive resistance to lincosamide, and streptogramin B 
antimicrobials (macrolide, lincosamide, and streptogramin B phenotype - iMLSB or cMLSB) 
Figure 1.8. Evaluation of macrolide phenotypes: A) Double disk test showing the cMLSB phenotype in a 
bovine Streptococcus agalactiae strain; B) control strain Staphylococcus aureus ATCC® 25923 used to 
monitor disk diameter (mm) of erythromycin (macrolide antimicrobial) and pirlimycin (lincosamide 
antimicrobial) according to the guidelines described before (CLSI, 2008). 
Antimicrobial disks used: erythromycin (15μg) and pirlimycin (2μg) (Oxoid®, Basingstoke, England). 
(Photos: Márcia G. Rato, FCT/UNL) 
A B
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(Weisblum, 1995). The M phenotype is associated with the presence of the genetic determinant 
mefA which encodes a pump conferring resistance to the 14- and 15-membered macrolides. 
Resistance to lincosamide and susceptibility to erythromycin (L-phenotype) has been previously 
observed in streptococci of human and animal origin (Malbruny et al., 2004; Haenni et al., 
2010[a]). The L (or LSA) phenotype is thought to be associated with the presence of linB gene, 
known to be carried by a plasmid of Enterococcus faecium from human origin (Bozdogan et al., 
1999). 
 
Tetracycline is no longer indicated for the treatment of bovine mastitis-associated streptococci 
in Portugal (http://www.apifarma.pt/simposiumvet/Paginas/Pesquisaavancada.aspx). 
Resistance to tetracycline among streptococcal isolates is frequently found in high rates in 
different countries (Kaspar, 2006; Hendriksen et al, 2008). 
The genes encoding resistance to tetracycline are usually acquired via transferable plasmids or 
transposons which also carry erythromycin resistance genes. For example, the association of 
tetracycline/macrolide determinants tetM/ermB, tetO/mefA, tetO/ermA, or tetO/mefA, has been 
previously described to be co-transferred in the same genetic elements among S. pyogenes 
strains (Brenciani et al., 2007; Giovanetti et al., 2003; D’Ercole et al., 2005; Brenciani et al., 
2010). The tetS gene (a tetracycline resistance gene) is known to be carried by integrative 
conjugative elements among human S. dysgalactiae subsp. equisimilis strains (Liu et al., 2008). 
Overall this justifies surveillance for presence of antimicrobial resistance genes among bovine 
field strains in order to assess the route and dissemination of these genes. 
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The main goal of the study was to provide knowledge about the molecular epidemiology, 
antimicrobial resistance phenotypes and genotypes and virulence traits of streptococcal species 
(S. agalactiae, S. dysgalactiae subsp. dysgalactiae, and S. uberis) usually associated with 
bovine mastitis in dairy cows.  
 
The specific aims of this Thesis were: 
 
1. To document the molecular epidemiology and population structure of S. agalactiae, S. 
dysgalactiae subsp. dysgalactiae and S. uberis associated with mastitis to help 
improvement of bovine health in Portugal. The use of DNA sequencing based methods 
such as multilocus sequence typing (MLST) for strain characterization (available for S. 
agalactiae and S. uberis) will further allow to compare the diversity of strains of these 
species collected in Portugal and in other countries. 
 
2. To study the antimicrobial resistance and virulence genotypes in order to have a better 
insight into the incidence, routes and mediators of gene dissemination. The study of 
antimicrobial susceptibility patterns against antimicrobial drugs used in mastitis control 
will also contribute to help improvement of bovine health in Portugal. 
 
3. To compare virulence traits, particularly of phage origin, among S. dysgalactiae subsp. 
dysgalactiae strains from bovine origin associated with mastitis and severe invasive 
disease with strains of the human pathogens S. pyogenes and S. dysgalactiae subsp. 
equisimilis to further inspect the role of phages and other mobile genetic elements in 
lateral gene transfer. 
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Abstract 
 
The molecular epidemiology and population structure of 30 bovine subclinical mastitis field 
isolates of Streptococcus uberis, collected from 6 Portuguese herds (among 12 farms screened) 
during 2002 and 2003, were examined by using pulsed-field gel electrophoresis (PFGE) for 
clustering of the isolates and multilocus sequence typing (MLST) to assess the relationship 
between PFGE patterns and to identify genetic lineages. The 30 isolates were clustered into 18 
PFGE types, using a similarity cutoff of 80%, and 3 PFGE types accounted for almost half of 
the isolates (46.6%). These major types were herd specific, suggesting either cow-to-cow 
transmission or infection with isolates from the same environmental reservoirs. The remaining 
unrelated PFGE types of isolates were from different herds strongly suggesting environmental 
sources of S. uberis infection. All 30 isolates were analyzed by MLST and clustered into 14 
sequence types (ST). These ST were found to be novel, either with 10 new alleles of 6 
housekeeping genes or with different combinations of previously assigned alleles. Five of these 
ST were clustered into 3 clonal complexes (lineages), ST-143, ST-86, and ST-5, known to 
include bovine isolates from several geographic locations (Australia, New Zealand, United 
Kingdom, Sweden, and Denmark) and 9 singletons. To our knowledge, this is the first report 
that documents molecular typing studies of bovine isolates of S. uberis from Portugal, which 
were shown to represent novel genomic backgrounds of this pathogen. 
 
 
 
 
 
 
 
 
 
 
 
 
Keywords 
 
Bovine mastitis, Streptococcus uberis, pulsed-field gel electrophoresis, multilocus sequence 
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2.1. Introduction 
 
Bovine mastitis remains a major cause of economic loss in the dairy industry worldwide, despite 
the widespread implementation of mastitis control strategies. Economic losses are caused 
mainly by decreased milk production, early culling and death of the animals (Seegers et al., 
2003), and increased antibiotic therapy (Erskine et al., 2003). 
Contagious mastitis pathogens (such as S. agalactiae and S. aureus) have been brought under 
control in dairy herds through use of management practices (Bramley and Dodd, 1984; Bradley, 
2002). However, mastitis pathogens traditionally classified as environmental are not well 
controlled by these methods and are, in several countries, the most frequent cause of subclinical 
and clinical mastitis in both lactating and nonlactating cows, particularly on well-managed 
farms (Bradley, 2002). Mastitis due to S. uberis infection was generally considered the result of 
environmental exposure to this pathogen (Lopez-Benavides et al., 2007); however, cases of 
cow-to-cow transmission of S. uberis have been reported (Douglas et al., 2000; Phuektes et al., 
2001; Zadoks et al., 2003). 
Methods based on DNA have been successfully used in epidemiological studies aiming to 
evaluate strain-specific transmission and to improve infection control measures (Khan et al., 
2003; Wieliczko et al., 2002; Zadoks et al., 2003). Pulsed-field gel electrophoresis (PFGE) is 
the most discriminatory method and has been used for typing a broad range of pathogens 
including bovine (Baseggio et al., 1997; Wang et al., 1999; Douglas et al., 2000) and human 
pathogens, being most useful in outbreak investigations (Tenover et al., 1995; Van Belkum et 
al., 2007). Multilocus sequence typing (MLST) is a valuable tool that allows further 
investigation of the population structure and evolution of several pathogens (Maiden et al., 
1998; http://www.mlst.net/), including S. uberis (Pullinger et al., 2006; Pullinger et al., 2007). 
For S. uberis, 2 MLST schemes have been described, one based on sequencing of 6 loci that 
include virulence genes and housekeeping genes (Zadoks et al., 2005[b]) and the other based on 
the sequencing of 7 housekeeping genes (Coffey et al., 2006; http://pubmlst.org/suberis/). 
In this study we used PFGE and MLST (using the latter scheme referred to above) to 
characterize a collection of field isolates of S. uberis from subclinical bovine mastitis occurring 
in Portuguese herds during 2002 and 2003 and to document the molecular epidemiology and 
population structure of the isolates, which would be useful in providing further insights into the 
evolutionary and population genetics of this pathogen. 
 
2.2. Materials and Methods 
 
2.2.1. Streptococcus uberis collection 
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A total of 30 S. uberis field isolates causing bovine subclinical mastitis were included in this 
study. This collection comprised all S. uberis isolates (with the exception of 4 isolates that were 
lost during storage) recovered from February 2002 to March 2003, from 261 bovine milk 
samples of 215 animals with subclinical mastitis from 6 dairy farms (of 12 screened) located in 
the southwestern region of Portugal (Bexiga et al., 2005). The original study (Bexiga et al., 
2005) involved milk sampling of 459 quarters from 377 animals from 12 dairy herds. Selection 
criteria for the herds included in the study were geographical area and willingness of the farmers 
to participate in the study. The 12 herds enrolled in the study had a mean size of 248 lactating 
cows, a mean bulk tank SCC of 462,000 cells/mL, and a mean milk yield at 305 d of 7,987 kg 
of milk. Farms were all zero-grazed, which is typical of continental Portuguese herds. The 
program WinEpiscope 2.0 (Computer-aided Learning In Veterinary Education, CLIVE, 
University of Edinburgh, UK) was used to calculate the number of cows for milk sampling in 
each farm. Briefly, a representative number of animals (for an expected prevalence of 50% of 
subclinical mastitis at cow level, with a margin of error of 10% and a confidence level of 95%) 
was submitted to a California Mastitis Test, with quarters presenting a score of 3 being chosen 
for quarter sampling (score 3 on the California Mastitis Test, used to define subclinical mastitis 
on a scale of 0 to 3, with 0 being negative and 3 being strong positive). Quarters were only 
sampled once during the study period. Different sampling visits distant in time on the same farm 
depended on the calculated number of animals to sample. 
In total, 351 of 459 samples were positive for bacterial growth. Of those, S. uberis and S. aureus 
were found in 10% of the samples, S. agalactiae in 18.2%, and CNS in 34.5% (Bexiga et al., 
2005). 
The distribution of the 30 S. uberis isolates on the 6 farms (coded F, K, C, D, I, and J) was as 
follows: 18 isolates from farm F, 6 isolates from farm I, 3 isolates from farm K, and single 
isolates from farms C, D, and J. All isolates were collected from different animals. Detailed 
information about the 30 isolates, including source, date of isolation, and, where appropriate, 
the identification number, breed, and disease status of the cow is available on the S. uberis 
isolates MLST database (http://pubmlst.org/suberis/). 
 
2.2.2. Streptococcus uberis identification 
 
All isolates were cultured in sheep blood agar media and were identified as S. uberis using the 
API-20 STREP (bioMérieux, Marcy l’Etoile, France) and BBL Crystal Gram-Positive (Becton 
Dickinson and Co., Franklin Lakes, NJ) identification systems. Differentiation between S. 
uberis and S. parauberis, which are phenotypically indistinguishable (Facklam, 2002), was 
performed by PCR amplification of the 16S ribosomal DNA (rDNA) gene of all the isolates, 
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using generic primers for gram-positive bacteria (Takahashi et al., 1997) and sequencing with 
the same primers used for amplification. Automatic sequencing was carried out by Macrogen 
(Seoul, Korea) or by STAB-Vida (Lisbon, Portugal). Sequence data were edited using SeqMan, 
DNAstar (DNAstar Inc., Madison, WI). Each of the sequences of the 16S rDNA gene of the 30 
isolates was compared with the sequence of the 16S rDNA gene of S. uberis reference strain 
HN1 (GenBank accession no. AB023576) and then compared with the sequences of all the 
species deposited in the GenBank database using BlastN 
(http://www.ncbi.nlm.nih.gov/BLAST/). 
 
2.2.3. PFGE typing and cluster analysis 
 
The 30 S. uberis isolates were analyzed by PFGE as described previously (Chung et al., 2000). 
Briefly, a 6-mL culture of cells in early stationary phase was harvested and washed in 1 mL of 
Tris-NaCl buffer (10 mM Tris, pH 8; 1 M NaCl), and resuspended in 200 μL of the same buffer. 
Concentrations were adjusted to an optical density of 5.0 at 620 nm. This cell suspension was 
then diluted 1:1 with 150 μL of 1.5% low-gelling temperature agarose (SeaPlaque, FMC 
Bioproducts, Rockland, ME) in the same Tris-NaCl buffer; disks of 20 μL were allowed to 
solidify for 5 min at −20°C. The cells were lysed by incubation of the disks at 37°C for 5 h with 
50 μg of RNase I, 1 mg of lysozyme, and 5 U of mutanolysine in 1 mL of lysis buffer (6 mM 
Tris, pH 8, 1 M NaCl, 0.1 M EDTA, pH 8, 0.2% deoxycholate, 0.5% sarkosyl, 0.5% Brij 58). 
The disks were next incubated in a solution of proteinase K (1 mg/mL) in EDTAsarkosyl buffer 
(0.5 M EDTA, pH 9, 1% Sarkosyl) at 50°C for 18 h. The agarose disks were washed 8 times in 
13 mL of Tris-EDTA buffer (10 mM Tris, 1 mM EDTA, pH 7.5) for 30 min with gentle 
agitation. The DNA was then considered purified and was stored in approximately 1 mL of 
Tris-EDTA buffer at 4°C. The DNA was digested with 20 U of SmaI (New England BioLabs, 
Beverly, MA), and PFGE was performed in a CHEF DR-III (contour-clamped homogeneous 
electric field) apparatus (Bio-Rad, Hercules, CA) for 23 h. The running parameters were as 
follows: initial pulse = 5 s; final pulse = 35 s; voltage = 200 V; temperature = 11.3°C. Ethidium 
bromide (0.5 μg/mL) was used to stain the gels. Images were captured using the Gel Doc XR 
system and the Quantity One 1-D Analysis Software (Bio-Rad). The PFGE lambda marker 
(New England Biolabs) was used as a molecular weight standard. 
All PFGE profiles or patterns were analyzed visually and by computer-assisted cluster analysis 
using the software BioNumerics v. 4.0 (Applied Maths, Sint-Martens-Latem, Belgium). Levels 
of similarity between fingerprints were calculated by using Dice coefficient, and an unweighted 
pair group method using arithmetic averages (UPGMA) was used for clustering to produce 
band-based dendrograms (with a band position tolerance of 1.5% and no optimization). Groups 
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of patterns with no observed band differences (corresponding to a level of similarity of 100%) 
were considered indistinguishable and were assigned to the same subtype of a PFGE type. 
Patterns with variation up to 6 bands were considered related according to previous suggested 
criteria (Tenover et al., 1995) and were clustered in most cases above 80% similarity. These 
were assigned to different subtypes of a PFGE type. Patterns with variation of 6 or more bands 
(corresponding to levels of similarity of less than 80%) were not considered related and were 
assigned to distinct PFGE types. All PFGE types were designated with uppercase letters and 
each of their subtypes (subclonal variants) was identified in addition by a numeral suffix. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.2.4. MLST and eBURST analysis 
 
All isolates were analyzed by MLST. The DNA was extracted as described for Group A 
Streptococcus at http://www.cdc.gov/ncidod/biotech/strep/protocol_emm-type.htm. The primers 
used were described previously (www.pubmlst.org/suberis/info/protocol.shtml; Coffey et al., 
2006). The PCR amplification reactions were adapted from the method available at the S. uberis 
MLST Web site (www.pubmlst.org/suberis/info/protocol.shtml). A 50-μL reaction included 
1.25 U of Taq polymerase (MBI Fermentas, Vilnius, Lithuania), 30 pmol of each primer, 1.5 
Figure 2.1. Pulsed-field gel electrophoresis (PFGE) profiles of SmaI-digested genomic DNA from 
Streptococcus uberis subclinical mastitis isolates collected at 6 Portuguese dairy herds. Ladder = Lambda 
PFGE ladder marker (New England BioLabs, Beverly, MA). PFGE type-subtype is designated in top of 
the images, each isolate code name is designated under the images, as well as the farms from where they 
were collected, which are designated in capital letters. 
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mM MgCl2 (MBI Fermentas), 200 μM of deoxynucleoside triphosphate mix (MBI Fermentas), 
and 2 μL of DNA. The PCR amplicons were purified using the Wizard PCR Preps DNA 
Purification System (Promega, Madison, WI), and sequencing was performed as described 
above. The sequences were entered at the S. uberis MLST database 
(www.pubmlst.org/suberis/info/protocol.shtml) and novel alleles were assigned new numerals. 
The allelic profile and sequence type (ST) of each isolate are available at the S. uberis MLST 
database (www.pubmlst.org/suberis/info/protocol.shtml).  
The predicted evolutionary descent of the isolates was evaluated by using e-BURST 
(http://eburst.mlst.net/) of S. uberis data set (eBURSTv3 – Streptococcus uberis), which 
included 1 example of each ST assigned at the S. uberis MLST database. This tool produces a 
diagram displaying the way each clonal complex may have emerged and diversified from the 
predicted founding genotype. This diagram is centered on the predicted founding genotype, and 
the branches represent the predicted descent to the other genotypes in the group. The eBURST 
uses lines to show radial links from the founder to each of its single locus variant (initial 
diversification). Only single locus variant links are shown in an eBURST diagram. All isolates 
that are directly linked on an e-BURST diagram will therefore differ at only a single locus, and 
the cluster of linked ST represents a clonal complex. 
 
2.3. Results 
 
2.3.1. 16S rDNA gene sequence analysis for Streptococcus uberis identification 
 
Comparative analysis with the 16S rDNA gene sequence of the S. uberis reference strain HN1 
from the GenBank database showed that out of the 30 isolates, 13 had maximum identity of 
100%, 16 isolates differed by 1 bp, corresponding to a maximum identity of 99%, and 1 isolate 
differed by 3 bp, which also corresponded to a maximum identity of 99%. These variations have 
been described as microheterogeneity in the 16S rDNA gene sequence within the same species 
or intraspecies variation of the 16S rDNA gene sequence (Clarridge, 2004). Moreover, 
sequences of the 16S rDNA gene of streptococcal species other than S. uberis (including S. 
parauberis) deposited in the GenBank database were <99% identical to the 16S rDNA gene 
sequences of the S. uberis isolates from the present work. Therefore, we have considered all the 
isolates as S. uberis taking into account the phenotype and this genotypic tool used for 
identification. 
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2.3.2. PFGE profiles 
 
Patterns obtained by PFGE ranged from 9 to 15 well-resolved fragments of approximately 10 to 
485 kb (Fig. 2.1). Percentage similarity among patterns was determined by cluster analysis in a 
dendrogram (Fig. 2.2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
Figure 2.2. Dendrogram of the pulsed-field gel electrophoresis (PFGE) profiles of Streptococcus uberis 
subclinical mastitis isolates, collected at 6 Portuguese dairy herds. Isolate code, farm code, and date of 
isolation of each strain, and novel multilocus sequence types (ST) and clonal complexes are also 
designated in the dendrogram. The dendrogram was produced by using Dice coefficients and an 
unweighted pair group method using arithmetic averages (UPGMA). Default clustering settings of 0.00% 
optimization (i.e., the relative distance an entire lane is allowed to shift in matching attempts) and 1.5% 
band position tolerance were used. Plausible related groups (>80% similarity), or clusters, are designated 
in rectangles. When isolates belonging to a same cluster were collected at different dates, a green circle is 
indicated. ST, sequence type. 
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Epidemiologically plausible groups (clusters) were identified using the cut-off of at least 80% 
similarity as described above. Three major clusters (named I, II, and III) included more than 2 
isolates at 80% or greater similarity levels (Fig. 2.2). Cluster I included 4 isolates from farm F. 
Two isolates (vsu6 and vsu9, collected within a 4 month interval from 2 cows) had 
indistinguishable patterns (no observed band differences; see Fig. 2.1) corresponding to a level 
of similarity of 100% and were assigned to a same PFGE subtype (A-1) of PFGE type A. The 2 
remaining patterns differed by up to 3 bands between isolate pairs and were assigned to 
different PFGE subtypes (A-2, A-3). The 3 subtypes have 83.3% similarity. Cluster II included 
4 isolates also from farm F, whose patterns differed by 1 to 6 bands between isolate pairs and 
were assigned to different PFGE subtypes (B-1 to B-4) of PFGE type B with similarity levels 
ranging from 96.3 to 80.1%. Cluster III included 6 isolates from farm I, whose patterns differed 
by 1 to 5 bands between isolate pairs and were assigned to different PFGE subtypes (C-1 to C-
6) of PFGE type C with similarity levels ranging from 96.0 to 81.6%. A minor cluster 
comprised 2 other isolates from farm F whose patterns differed by 3 bands and were assigned to 
different PFGE subtypes (D-1, D-2) of PFGE type D with 82.8% similarity. The remaining 
isolates were not clustered and were assigned to unique PFGE subtypes. 
 
2.3.3. Allelic profiles and sequence types of Portuguese Streptococcus uberis isolates 
 
The sequences of the 7 gene fragments used for the MLST scheme were determined for all 30 
isolates confirmed to be S. uberis. These isolates were clustered into 14 ST, all found for the 
first time in this study. These ST were novel because they had different combinations of 
previously assigned alleles (ST-267, ST-285, ST-286, ST-287, ST-289, and ST-290) or 
contained 10 new alleles of 6 housekeeping genes (ST-265, ST-266, ST-268, ST-269, ST-270, 
ST-284, ST-288, and ST-291; Table 2.1). Within the same cluster (I, II, or III), isolates had the 
same ST: cluster I included 4 isolates of ST- 265, cluster II included 4 isolates of ST-268, and 
cluster III included 6 isolates of ST-267 (Fig. 2.2). Some of the PFGE subtypes with <80% 
similarity shared the same ST: PFGE subtypes F-1, G-1, and PFGE subtypes B-1 to B-4 of 
cluster II with 70.4% of similarity shared the same ST (ST-268); PFGE subtype H-1 and PFGE 
subtypes D-1 to D-2 with 77.9% of similarity shared the same ST (ST-268; Fig. 2.2). 
The 18 isolates of farm F were of seven ST (ST-265, ST-266, ST-268, ST-269, ST-284, ST-287, 
and ST-288) and 11 PFGE types. The 6 isolates of farm I were of a single ST (ST-267) and a 
unique PFGE type (with 6 subtypes). The 3 isolates of farm K were of 3 ST (ST-285, ST-286, 
and ST-289) and of 3 unrelated PFGE types. The single isolates from farms C, J, and D were of 
ST-270, ST-290, and ST-291, respectively, and of 3 unrelated PFGE types (Table 2.1). 
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Three clonal complexes or genetic lineages were assigned primarily by the S. uberis MLST 
database curator and all included isolates of single PFGE subtypes. Lineage ST-143 included 3 
ST (ST-284, ST-288, and ST-269) of 3 isolates from farm F (vsu2, vsu29, and vsu15) and 
additionally 122 S. uberis strains from dairy herds in Australia, New Zealand, and the UK; 
lineage ST-5 included the ST-287 of another isolate from farm F (vsu27) and also of 170 S. 
uberis strains from dairy herds in Australia, Denmark, New Zealand, Sweden, and the UK; 
lineage ST-86 included ST-286 of 1 isolate from farm K (vsu11) and of 41 other S. uberis 
strains from dairy herds in Australia, New Zealand, Sweden, and the UK (data from 
pubmlst.org/suberis). The remaining 9 ST from this study were singletons. 
 
 
 
 
 
 
 
Allele Farm 
code 
Isolate 
code 
PFGE 
Type - 
subtype arcC ddl gki recP tdk tpi yqil 
Sequence 
Types2 
(ST) 
Clonal 
Complex3 
(ST) 
e-
BURST 
Group 
F vsu6 A-1 4 1 261 3 2 2 5 265   
F vsu9 A-1 4 1 261 3 2 2 5 265   
F vsu14 A-2 4 1 261 3 2 2 5 265   
F vsu31 A-3 4 1 261 3 2 2 5 265   
F vsu8 L-1 2 10 2 1 381 4 271 266   
I vsu10 C-1 9 1 5 3 17 4 10 267   
I vsu21 C-5 9 1 5 3 17 4 10 267   
I vsu23 C-2 9 1 5 3 17 4 10 267   
I vsu17 C-3 9 1 5 3 17 4 10 267   
I vsu22 C-4 9 1 5 3 17 4 10 267   
I vsu30 C-6 9 1 5 3 17 4 10 267   
F vsu4 G-1 9 1 271 2 391 1 17 268   
F vsu13 B-1 9 1 271 2 391 1 17 268   
F vsu26 B-2 9 1 271 2 391 1 17 268   
F vsu12 B-3 9 1 271 2 391 1 17 268   
F vsu20 B-4 9 1 271 2 391 1 17 268   
F vsu1 F-1 9 1 271 2 391 1 17 268   
F vsu7 D-1 9 1 271 2 391 1 17 268   
F vsu18 D-2 9 1 271 2 391 1 17 268   
F vsu16 H-1 9 1 271 2 391 1 17 268   
F vsu15 Q-1 381 1 2 2 29 4 3 269 143  
C vsu19 I-1 6 1 5 141 17 1 3 270   
F vsu2 E-1 9 1 2 2 421 2 3 284 143  
K vsu3 K-1 6 16 5 2 17 1 3 285   
K vsu11 R-1 10 1 3 3 13 1 3 286 86  
F vsu27 N-1 1 1 2 2 16 1 3 287 5 1 
F vsu29 M-1 381 1 2 2 22 4 3 288 143  
K vsu5 P-1 10 1 3 2 13 1 10 289   
J vsu25 J-1 1 1 5 2 10 1 3 290   
D vsu28 O-1 2 271 5 1 431 1 3 291   
Table 2.1. Allelic profiles and clonal complexes of Streptococcus uberis isolates of bovine subclinical 
mastitis from Portugal assigned by multilocus sequence typing (MLST). 
1PFGE = pulsed-field gel electrophoresis. 
2Novel allelic profiles or sequence types (ST). 
3MLST clonal complexes (clusters of linked ST) assigned by the S. uberis MLST database curator. 
4Novel allele. 
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The e-BURST analysis revealed that only ST-287 from this study of lineage ST-5 was included 
in a clonal complex described as group 1 by eBURSTv3 – Streptococcus uberis software 
(http://eburst.mlst.net/; Fig. 2.3); ST-287 was found to be a single locus variant of the predicted 
founder (ST-184) of this major clonal complex (Fig. 2.3), which includes 107 ST of the S. 
uberis MLST database. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.4. Discussion 
 
Streptococcus uberis is one of the most prevalent pathogens in dairy herds and is considered one 
of the principal causative agents of bovine mastitis, a very costly disease in dairy industry 
(Leigh, 1999; Shim et al., 2004). It has been noted that the relative importance of transmission 
mechanisms and control measures differs between herds and geographical areas (LeBlanc et al., 
2006). However, studies on the molecular characterization of field S. uberis isolates from 
Figure 2.3. e-BURST diagram determined by eBURSTv3 software (http://eburst.mlst.net/) using 1 
example of each sequence type (ST) assigned in the Streptococcus uberis multilocus sequence typing 
(MLST) database (http://pubmlst.org/suberis/info/protocol.shtml). Only ST-287 (pointed out in red) from 
the present work was assigned to the major clonal complex described as group 1, which includes 107 ST 
of S. uberis MLST database; ST-287 is a single locus variant (SLV) of the predicted founder ST-184 (blue 
circle). 
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Portugal are still not documented and are of utmost importance for a more efficient control of 
bovine mastitis caused by this pathogen. 
This species, together with the contagious pathogen S. aureus, accounted for 10% of all milk 
samples with positive growth, S. agalactiae accounted for 18.2%, and CNS accounted for 
34.5%, during 2002 and 2003, from a study on bovine subclinical mastitis among 12 
commercial dairy farms in a particular region of Portugal (Bexiga et al., 2005). Greater 
prevalence rates of S. uberis have been reported in other countries such as New Zealand 
(Douglas et al., 2000) because the dairy industry there is mainly pasture based. However, 
continental Portuguese herds are typically zero-grazed, which could explain lower rates of S. 
uberis infection. Moreover, among the 12 commercial dairy farms screened, S. uberis was found 
on only 6 farms (50%). 
Our aim was to assess if subclinical bovine mastitis episodes were associated with multiple 
PFGE types or with a limited number of dominant types, which is important information for the 
implementation of targeted mastitis control programs. Additionally, we aimed to document the 
genotypic properties of this species in a region not yet surveyed, contributing to increased 
knowledge about the evolutionary and population genetics of this pathogen by using MLST. 
The combined use of the molecular typing techniques mentioned above was a valuable approach 
to achieve our aims. The prevalence of S. uberis varied between herds. The totality of the S. 
uberis isolated in the survey by Bexiga et al. (2005) were included in the present study. Close to 
half (44.4%; n = 8/18) of the S. uberis isolates from farm F (n = 18) were clustered into 2 large 
homogeneous PFGE groups, clusters I and II. Moreover, all the S. uberis isolates from farm I (n 
= 6) were clustered in 1 PFGE homogeneous group (cluster III). 
The finding of a limited number of dominant PFGE clusters or PFGE types spread over farms F 
and I rather than a wide heterogeneity of PFGE types strongly suggested that cows might have 
been the source of infections or that acquisition from a common environmental source occurred. 
Despite that, other heterogeneous PFGE types were detected on farm F, which suggests that 
several environmental sources might have been the source of infections or that the replacement 
policy on that farm relied more heavily on buying in animals than occurred on other farms. 
Related isolates, according to the PFGE data, were seen to share the same ST; however, PFGE 
and MLST did not correlate in all cases. Isolates of unrelated PFGE types F, G, and B (70.4% 
similarity) were found to share the same ST (ST-268; Fig. 2.2). In addition, H and D (77.9% 
similarity) shared ST-268. This result was expected because PFGE is sensitive to microvariation 
and, therefore, often has more discriminatory power (Van Belkum et al., 2007) than MLST, 
which detects variation that accumulates slowly in housekeeping genes (Maiden et al., 1998). 
Moreover, different PFGE subtypes of a same type were observed among isolates from different 
cows within the same herd collected on the same day of sampling. Examples are isolates of 
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PFGE B-1 to B-4 from farm F or isolates of PFGE C-1 to C-4 from farm I (Fig. 2.2.). In 
contrast, and of interest, was the finding of 2 isolates with indistinguishable PFGE patterns 
(100% similarity; PFGE subtype A-1) collected from 2 cows on farm F collected within a 4-
month interval, which strongly suggests that infection of both cows was caused by the same 
strain, either because of transmission during milking or by close contact with the same 
environmental reservoir. Clarification of the importance of these environmental reservoirs to the 
incidence of infection by typing isolates from different sites on the cow and environmental sites 
will be required in the future. Nevertheless, the observed differences in PFGE banding patterns 
may be due to genetic changes in persisting strains within these herds. 
Prevalence of S. uberis clones as well as persistent S. uberis strains within the same herd have 
been reported previously (Phuektes et al., 2001; Zadoks et al., 2003), although most studies 
found that the point source of infection is uncommon and the main route of transmission is 
through environmental sources (Khan et al., 2003; Tomita et al., 2008). These disparities in the 
epidemiology of S. uberis may reflect differences among production systems (McDougall et al., 
2004). 
More variability was expected between related isolates collected at sampling visits distant in 
time. In fact, different PFGE subtypes of a same type were observed among isolates from 
different cows within the same herd collected at 4-month or 10-month intervals between 
sampling. Examples are isolates of PFGE A-1 to A-3, D-1 and D-2 from farm F, or isolates of 
PFGE C-1 to C-4 and isolates C-5 or C-6 from farm I (Fig. 2.2). 
As noted above, in most cases, the MLST results agreed with the fingerprinting data and 
allowed us, in addition, to infer a population structure for our collection of isolates. All of the 
ST found in this study were novel, either with 10 new alleles of 6 housekeeping genes or with 
different combinations of previously assigned alleles. Presently, the S. uberis profile database 
consists of 291 profiles. Among these, ST-265 to ST-270 and ST-284 to ST-291 were the ones 
described in this study. Interestingly, the 2 large homogeneous PFGE clusters I and II, which 
grouped almost half (44.4%) of the S. uberis from farm F were judged as singletons (ST-265 
and ST-268) by MLST. On the other hand, the remaining isolates that were dispersed by minor 
and unique PFGE patterns and grouped into 4 sequence types (ST-269, ST-284, ST-288, and 
ST-287) were clustered into 2 clonal complexes or lineages (ST-5 and ST-143). It was 
suggested that isolates belonging to clonal complexes ST-5 and ST-143 might possess virulence 
factors promoting invasion of host tissue, survival in the host environment, evasion of the host 
immune response, or internalization in the mammary gland (Tomita et al., 2008). Moreover, a 
link was observed between clonal complexes ST-5 and ST-143 and carriage of the hasA 
virulence gene (Coffey et al., 2006; Pullinger et al., 2006). 
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It is intriguing why only the singletons from farm F, rather than the major PFGE cluster I and 
cluster II (also from farm F), were assigned to these virulent clonal complexes, because these 
strains might have been hypertransmissible among cows, and therefore would be expected to be 
more virulent. Our data suggest that strains other than those of clonal complexes ST-5 and ST-
143 are also hypervirulent strains. 
The occurrence of identical ST between Portugal and other countries was not detected. All ST 
found in the present work are unique and were found for the first time in this collection, which 
would be expected because information regarding mastitis isolates from Mediterranean 
countries is lacking in the MLST database. Nevertheless, ST-287 from the present study was 
found to be a single locus variant of the predicted founder ST-184 of the major group 1 clonal 
complex (http://eburst.mlst.net); ST-184 includes one strain from clinical mastitis in Australia 
and strains from environmental sources in New Zealand. 
 
2.5. Conclusions 
 
In conclusion, it seems that the contagious route of mastitis infection is still a problem in 
Portugal. High prevalence of the contagious mastitis pathogens S. agalactiae and S. aureus was 
found among the subclinical mastitis milk samples collected during the original study period 
(Bexiga et al., 2005). Although S. uberis is traditionally classified as an environmental 
pathogen, it may also be transmitted from cow to cow, probably through the milking process. 
The PFGE analysis in the present study supports this view, as we observed that a limited 
number of dominant PFGE types spread in farms F and I (which accounted for 46.6% of all 
isolates). Nevertheless, acquisition from a common source may also be occurring: all farms 
were zero-grazed and, therefore, infection with S. uberis from environmental reservoirs such as 
pastures was not expected. These results may reflect a possible defect in the implementation of 
mastitis control programs on these farms, and better policies for herd management may be 
needed. Interestingly, presumably more virulent strains (assigned to virulent clonal complexes) 
were associated with single PFGE types and not with clonal spread. To our knowledge, this is 
the first report describing genetic relationships among bacterial isolates of bovine S. uberis from 
Portugal, which were shown to represent novel genomic backgrounds and unique genotypes of 
this pathogen. 
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Abstract 
 
 
Phage-encoded virulence genes of group A streptococci were detected in 10 (55.6%) of 18 
isolates of group C streptococci that had caused bovine mastitis. Bovine isolates carried other 
genetic determinants, such as composite transposon Tn1207.3/Φ10394.4 (100%) and 
antimicrobial drug resistance genes ermB/ermA (22.2%), linB (16.6%), and tetM/tetO (66.7%), 
located on mobile elements. 
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3.1. Introduction 
 
Strains of Streptococcus dysgalactiae subsp. dysgalactiae are described as alpha-hemolytic or 
non-hemolytic (Lancefield group C) and associated only with animal infections (bovine 
mastitis), a disease with major economic consequences for the dairy industry (Vieira et al., 
1998). Group A streptococci (GAS) specific phage-associated virulence determinants encoding 
pyrogenic exotoxins or superantigens (speM, ssa), which are strongly associated with severe 
diseases such as scarlet fever, streptococcal toxic shock syndrome, and rheumatic fever, have 
been described among human group C streptococci (GCS) or group G streptococci (GGS) (S. 
dysgalactiae subsp. equisimilis) (Igwe et al., 2003) but not among alpha-hemolytic GCS (S. 
dysgalactiae subsp. dysgalactiae) of bovine origin. In contrast, M protein or M-like proteins 
were found in human GGS/GCS (S. dysgalactiae subsp. equisimilis) and in animal GCS (S. 
dysgalactiae subsp. dysgalactiae) but only in beta-hemolytic strains (Zhao et al., 2007). 
Composite transposons and other genetic determinants also considered to be located in specific 
mobile elements such as macrolide (either encoding methylases [erm genes] or efflux pumps 
[mef genes]) and tetracycline resistance determinants (tet genes) have been found among 
streptococcal species of human origin. We studied a collection of field isolates of bovine GCS 
S. dysgalactiae subsp. dysgalactiae to search for genetic determinants, particularly those carried 
by mobile elements known to be transferred among human GAS and GGS/GCS. 
 
3.2. Materials and Methods 
 
We studied 18 alpha-hemolytic S. dysgalactiae subsp. dysgalactiae field isolates of Lancefield 
group C that had caused bovine subclinical mastitis. Isolates were obtained from 304 milk 
samples of 248 cows from 8 farms in Portugal that were included in the study. Detailed 
information regarding isolation methods and identification of field isolates by biochemical 
methods were described in Chapter 3 (identification by biochemical methods was carried as 
described for S. uberis). 
To confirm identification of S. dysgalactiae subsp. dysgalactiae, the 16S rRNA gene was 
amplified by PCR and sequenced (Weisburg et al., 1999). SmaI/cfr9I-digested DNA banding 
patterns were obtained by pulsed-field gel electrophoresis for clone identification performed as 
described for the pathogen S. uberis (see Chapter 2). 
All virulence genes and antimicrobial resistance genes analyzed by PCR in the present study are 
described in Table 3.1 and Table 3.2, respectively. The emm gene subtyping was performed as 
described (www.cdc.gov/ncidod/biotech/strep/M-ProteinGene_typing.htm). 
Samples without DNA and strains lacking (negative) or carrying (positive) specific genes were 
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used as controls in the PCR. Results were consistent in 2 or 3 PCRs that included these controls.  
 
 
 
 
 
 
Primer name Sequence (5’-3’) Product 
(bp) 
Reference 
Prophage-associated virulence determinants   
Pyrogenic exotoxins:    
ssa (for.) 
ssa (rev.) 
GTGTAGAATTGAGGTAATTG 
TAATATAGCCTGTCTCGTAC 
706 Pires et 
al., 2009 
speA (for.) 
speA (rev.) 
CTTAAGAACCAAGAGATGGC 
ATAGGCTTTGGATACCATCG 
200 Pires et 
al., 2009 
speC (for.) 
speC (rev.) 
CATCTATGGAGGAATTACGC 
TGTGCCAATTTCGATTCTGC 
246 Pires et 
al., 2009 
speH (for.) 
speH (rev.) 
AGATTGGATATCACAGG 
CTATTCTCTCGTTATTGG 
416 Pires et 
al., 2009 
speI (for.) 
speI (rev.) 
AAGGAAAAATAAATGAAGGTCCGCCAT 
TCGCTTAAAGTAATACCTCCATATGAATTCTTT 
217 Lingtes et 
al., 2007 
speJ (for.) 
speJ (rev.) 
ATCTTTCATGGGTACG 
TTTCATGTTTATTGCC 
535 Pires et 
al., 2009 
speK (for.) 
speK (rev.) 
TATCGCTTGCTCTATACACTACTGAGAGT 
CCAAACTGTAGTATTTTCATCCGTATTAAA 
233 
 
Lingtes et 
al., 2007 
speL (for.) 
speL (rev.) 
GGACGCAAGTTATTATGGATGCTCA 
TTAAATAAGTCAGCACCTTCCTCTTTCTC 
460 Lingtes et 
al., 2007 
speM (for.) 
speM (rev.) 
GCTTTAAGGAGGAGGAGGTTGATATTTATGCTCTA 
CAAAGTGACTTACTTTACTCATATCAATCGTTTC 
411 Lingtes et 
al., 2007 
DNAse1:    
spd1 (for.) 
spd1 (rev.) 
CCCTTCAGGATTGCTGTCAT 
ACTGTTGACGCAGCTAGGG 
400 Green et 
al., 2005 
Phospholipase A2e:    
slaA (for.) 
slaA (rev.) 
CTCTAATAGCATCGGCTACGC 
AATGGAAAATGGCACTGAAAG 
440 Green et 
al., 2005 
Composite transposon:    
Tn1207.3/Φ10394.4 
R.J.* (for.) 
Tn1207.3/Φ10394.4 
R.J.* (rev.) 
CGAGGAGTTAGTATGGAAAC 
 
CCCATAATAGGCAACTGGTCTCCAGC 
473 Figueiredo 
et al., 
2006 
Tn1207.3/Φ10394.4 
L.J.† (for.) 
Tn1207.3/Φ10394.4 
L.J.† (rev.) 
TCTTCGCCGCATAAACCCTATC 
 
CCTTTGACCAATGAAGTGACCTTT 
453/6,807‡ Figueiredo 
et al., 
2006 
M protein    
emm (for.) 
emm (rev.) 
TATTCGCTTAGAAAATTAA 
GCAAGTTCTTCAGCTTGTTT 
variable ** 
Table 3.1. Virulence genes and primers used for the PCR analysis, among bovine GCS Streptococcus 
dysgalactiae subsp. dysgalactiae. 
*R.J.: right junction; †L.J.: left junction 
‡The expected ampicon size was 454 bp according to the reported organization of the Tn1207.3 element 
or 6,807 bp according to the reported sequence of Φ10394.4 (Figueiredo et al., 2006). 
**www.cdc.gov/ncidod/biotech/strep/M-ProteinGene_typing.htm 
 45  
Chapter 3 
Sequencing of all virulence gene amplicons was performed with the same primers used for 
amplification (STAB-Vida, Lisbon, Portugal). All sequences were compared with sequences in 
GenBank by using the BLAST alignment tool (www.ncbi.nlm.nih.gov/BLAST). 
 
 
3.3. Results 
 
We detected bacteriophage-associated virulence genes speM, speK, speC, spd1, and speL. The 
overall distribution of these GAS virulence genes in the bovine GCS isolates from the present 
Primer 
name 
Sequence (5’-3’) Product 
(bp) 
Reference 
Macrolide Resistance   
mefA (for) 
mefA 
(rev.) 
GACCAAAAGCCACAATTGTGGA 
CCTCCTGTCTATAATCGCATG 1432 Pires et al., 2005 
ermA 
(for.) 
ermA 
(rev.) 
CCCGAAAAATACGCAAAATTTCAT 
CCCTGTTTACCCATTTATAAACG 590 Pires et al., 2005 
ermB 
(for.) 
ermB 
(rev.) 
GGAGTGATACATGAACAAAAATA 
TTCCTTTTAGTAACGTGTAACTTT 531 Pires et al., 2005 
Tetracycline Resistance   
tetM (for.) 
tetM (rev.) 
TGGAATTGATTTATCAACGG 
TTCCAACCATACAATCCTTG 1080 Pires et al., 2005 
tetO (for.) 
tetO (rev.) 
AACTTAGGCATTCTGGCTCAC 
TCCCACTGTTCCATATCGTCA 515 Ng et al., 2001 
tetT (for.) 
tetT (rev.) 
AAGGTTTATTATATAAAAGTG 
AGGTGTATCTATGATATTTAC 169 Aminov et al., 2001 
tetW (for.) 
tetW (rev.) 
GAGAGCCTGCTATATGCCAGC 
GGGCGTATCCACAATGTTAAC 168 Aminov et al., 2001 
tetQ (for.) 
tetQ (rev.) 
TTATACTTCCTCCGGCATCG 
ATCGGTTCGAGAATGTCCAC 904 Ng et al., 2001 
tetS (for.) 
tetS (rev.) 
GAAAGCTTACTATACAGTAGC 
AGGAGTATCTACAATATTTAC 169 Aminov et al., 2001 
tetL (for.) 
tetL (rev.) 
TCGTTAGCGTGCTGTCATTC 
GTATCCCACCAATGTAGCCG 267 Ng et al., 2001 
tetK (for.) 
tetK (rev.) 
TCGATAGGAACAGCAGTA 
CAGCAGATCCTACTCCTT 169 Ng et al., 2001 
Lincosamide Resistance   
linB (for.) 
linB (rev.) 
CCTACCTATTGTTTGTGGAA 
ATAACGTTACTCTCCTATTC 925 
Bozdogan et al., 
1999 
Streptogramin A resistance   
vgaB (for.) 
vgaB 
(rev.) 
AAGTCGACTGACAATATGAGTGGTGG 
CTGCAGATGCCTCAACAGCATCGAATATCC 1051 Allignet & Solh, 1997 
Table 3.2. Antimicrobial resistance genes analyzed by PCR and primers used. 
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study, as well as other characteristics of the bovine strains are described in Fig. 3.1. All but 1 of 
the PCR products showed expected sizes (Table 3.1 and Table 3.2). The Tn1207.3/Φ10394.4 
composite transposon left junction amplicon showed a size of 380 bp instead of 453–6,807 bp 
as described for GAS (Figueiredo et al., 2006). No amplification was observed for the right 
junction of this genetic element. 
The emm gene encoding the antiphagocytic M surface protein was not amplified in any of the 18 
bovine GCS isolates; therefore, no emm types were obtained. 
Subsets of GCS isolates were erythromycin and pirlimycin resistant (MLSB phenotype) and 
contained ermB or ermA genes (22.2%) or erythromycin susceptible and pirlimycin resistant and 
contained the linB gene (16.6%). All isolates were tetracycline resistant with a subset (66.7%) 
carrying tetM or tetO tetracycline resistance determinants. See Chapter 5 for further details 
regarding results of patterns of antimicrobial drug resistance against macrolides (erythromycin), 
lincosamides (pirlimycin) and tetracycline, and macrolide phenotypes tested among the bovine 
GCS. 
Sequences of all virulence genes were compared by using the BioEdit sequence alignment 
editor (Hall, 1999). One different allele was found for each of the following gene sequences: 
spd1 (among 6 strains), speC (among 6 strains), and speL (among 4 strains). Three alleles were 
found for speK (among 8 strains) (speK-1, speK-2 and speK-3), and two alleles were found for 
speM gene sequences (among 2 strains) (speM-1, speM-2). Bovine alleles had sizes of 386 bp 
(spd1), 222 bp (speC), 444 bp (speL), 232 bp (speK), and 357 bp (speM). Examples of 
alignments between bovine virulence gene alleles with sequences from GenBank (only most 
similar ones) are shown in Fig. 3.2. 
 
3.4. Discussion 
 
Using PCR, we determined that bovine GCS S. dysgalactiae subsp. dysgalactiae strains (55.6%) 
carried >1 GAS-specific bacteriophage virulence-associated genes (spd1, speC, speK, speL, and 
speM). This finding suggested that bacteriophages may also play a role in the genetic plasticity 
and virulence of animal GCS. 
The speL allele from bovine strains showed higher similarity with the szeM allele (99% 
maximum identity) from S. equi subsp. zooepidemicus than with the speL allele (97% maximum 
identity) from S. pyogenes. The szeM gene encodes a superantigen in S. equi subsp. 
zooepidemicus, which is primarily a pathogen of nonhuman animal species. This organism 
causes mastitis in mares and cows and is most frequently found in horses (Alber et al., 2005). 
We also observed that the speM alleles found among bovine strains also showed higher 
similarity with superantigen-encoding gene szeL from S. equi subsp. zooepidemicus than with 
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speM gene sequence from S. pyogenes. Moreover, another allele (a speM allele) showed higher 
similarity with the sdm gene from S. dysgalactiae subsp. dysgalactiae than with the speM gene 
from S. pyogenes. 
The remaining alleles (spd1, speC, speK-1, and speK-2) from the GCS S. dysgalactiae subsp. 
dysgalactiae bovine strains showed high similarity with S. pyogenes superantigen genes (98%–
99% maximum identity). 
This finding supports our hypothesis that GAS prophages may play a role in the genetic 
plasticity of this pathogen. The speC and spd1 genes are known to be localized on the same 
GAS prophage (Banks et al., 2002), and both genes were in fact detected in 6 bovine GCS S. 
dysgalactiae subsp. dysgalactiae isolates in our study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
None of the 18 alpha-hemolytic group C S. dysglacatiae subsp. dysgalactiae bovine isolates in 
Figure 3.1. Dendrogram and pulsed-field gel electrophoresis (PFGE) profiles of group C streptococci 
(GCS) Streptococcus dysgalactiae subsp. dysgalactiae subclinical mastitis isolates from 8 dairy herds, 
Portugal. PFGE type-subtype, virulence genotype, antimicrobial drug resistance phenotypes, and 
genotypes of each isolate are indicated. The dendrogram was produced by using Dice coefficients and an 
unweighted pair group method using arithmetic averages (UPGMA). Default clustering settings of 0.00% 
optimization and 1.5% band position tolerance were used. Plausible related groups (>80% similarity), or 
clusters, are designated in rectangles. When isolates belonging to a same cluster were collected at 
different farms a green circle is indicated. *All isolates were negative for speA, ssa, speH, speJ, speI, slaA 
genes and for Tn1207.3/Φ10394.4 element right junction tested by PCR; **All isolates were negative for 
mefA, tetT, tetW, tetL, tetQ, tetS, and tetK genes; TET, resistance only to tetracycline; MLSB-TET, 
resistance to macrolide, lincosamides, streptogramin B and TET; L-TET, susceptibility to macrolides and 
resistance to lincosamides and TET; Tn1207.3/Φ10394.4 element left junction was detected in all isolates. 
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this study were typed by emm-typing because amplification products in the PCR specific for the 
M surface protein gene emm were not obtained. This result is consistent with those of a report 
that beta-hemolytic, but not alpha-hemolytic, group C S. dysglacatiae subsp. dysgalactiae 
isolates of animal origin contained the emm gene (Zhao et al., 2007). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The successful amplification (380-bp product) of the left junction of the composite transposon 
Figure 3.2. Alignments of bovine group C streptococci (Streptococcus dysgalactiae subsp. dysgalactiae) 
alleles of virulence genes from 8 dairy herds, Portugal, with sequences from the National Center for 
Biotechnology (Bethesda, MD, USA) database showing base differences between sequences. The 
alignments were created by using BioEdit sequence alignment editor 
(www.mbio.ncsu.edu/BioEdit/bioedit.html). Nucleotide differences are shown in boldface. A) spd1 (99% 
maximum identity); B) speK (99% maximum identity); C) speC (99% maximum identity); D) speL–szeM 
(99% maximum identity); E) speL (97% maximum identity; F) speM alleles 1, 2, and 3 –szeL (98%–99% 
maximum identity); G) speM allele 4 (98% maximum identity). 
S. equi. zoo.: S. equi subsp.  zooepidemicus; MGAS8232/9429: S. pyogenes 
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in bovine isolates suggests that this mobile element may be inserted in a similar location, the 
comEC locus, as mapped in S. pyogenes and S. dysglactiae subsp. equisimilis. Absence or 
unexpected PCR products specific for any of the junctions of this element have been reported in 
other studies and attributed to possible lack of homology between the target and primers used 
(Figueiredo et al., 2006). 
Detection of the linB gene carried by a large conjugative plasmid (Bozdogan et al., 1999) in 3 of 
18 bovine GCS S. dysgalactiae subsp. dysgalactiae isolates is indicative of horizontal gene 
transfer. 
 
3.5. Conclusions 
 
Our findings indicate that alpha-hemolytic bovine GCS isolates, which are known to be 
environmental or contagious pathogens and a cause of bovine mastitis, may be reservoirs of 
virulence genes encoded by prophages of human-specific GAS. These genes encode exotoxins, 
superantigens, and streptodornases, which are responsible for GAS virulence and pathogenesis, 
and may be transferred to other streptococci of human origin by horizontal genetic transfer. 
Therefore, alpha-hemolytic isolates should not be disregarded as putative infectious disease 
agents in humans. 
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Abstract 
 
A custom-designed microarray containing 220 virulence genes of Streptococcus pyogenes 
(Group A Streptococcus [GAS]) was used to test group C Streptococcus dysgalactiae subsp. 
dysgalactiae (GCS) field strains causing bovine mastitis and group C or group G Streptococcus 
dysgalactiae subsp. equisimilis (GCS/GGS) isolates from human infections, with the latter 
being used for comparative purposes, for the presence of virulence genes. All bovine and all 
human isolates carried a fraction of the 220 genes (23% and 39%, respectively). The virulence 
genes encoding streptolysin-S, glyceraldehyde-3-phosphate dehydrogenase, the plasminogen-
binding M-Like protein PAM, and the collagen-like protein SclB were detected in the majority 
of both bovine and human isolates (94 to 100%). Virulence factors, usually carried by human 
beta-hemolytic streptococcal pathogens, such as streptokinase, laminin-binding protein, and C5a 
peptidase precursor, were detected in all human isolates but not in bovine isolates. Additionally, 
GAS bacteriophage-associated virulence genes encoding superantigens, Dnase, and/or 
streptodornase were detected in bovine isolates (72%) but not in the human isolates. 
Determinants located in non-bacteriophage-related mobile elements, such as the gene encoding 
R28, were detected in all bovine and human isolates. Several virulence genes, including genes 
of bacteriophage origin, were shown to be expressed by reverse transcriptase (RT-PCR). 
Phylogenetic analysis of superantigen gene sequences revealed a high level (>98%) of identity 
among genes of bovine GCS, of the horse pathogen Streptococcus equi subsp. equi, and of the 
human pathogen GAS. Our findings indicate that alpha-hemolytic bovine GCS, an important 
mastitis pathogen and considered to be a nonhuman pathogen, carries important virulence 
factors responsible for virulence and pathogenesis in humans. 
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4.1. Introduction 
 
Alpha-hemolytic Lancefield group C Streptococcus dysgalactiae subsp. dysgalactiae (GCS) is a 
pathogen frequently associated with clinical and subclinical bovine mastitis, a disease that 
causes major economic losses in the dairy industry (Vieira et al., 1998; Seegers et al., 2003). 
Virulence determinants have been identified in this pathogen, such as surface proteins which 
specifically interact with plasma or extracellular matrix proteins of the host, such as alpha-2-
macroglobulin, plasminogen, albumin, fibrinogen, fibronectin, vitronectin and collagen 
(Rantamäki & Müller, 1995; Mamo et al, 1987; Leigh et al., 1998; Valentin-Weigand et al., 
1990) and genes coding for proteins assumed to play a role in mastitis, such as alpha-2-
macroglobulin-, immunoglobulin G-, or immunoglobulin A- binding protein Mig (Jonsson & 
Müller, 1994; Song et al., 2004; Jonsson et al., 1994), alpha 2-macroglobulin-, or 
immunoglobulin G- binding protein Mag (Jonsson et al., 1994), and fibrinogen- binding M-like 
protein (Vasi et al., 2000). 
Recently, S. dysgalactiae subsp. dysgalactiae was reported to be associated with toxic shock-
like syndrome in cattle (Chénier et al., 2008), suppurative polyarthritis in lambs (Lacasta et al., 
2008), bacteremia in dogs (Vela et al., 2006), systemic granulomatous inflammatory disease 
and severe septicaemia in fish (Hagiwara et al., 2009) and in ascending upper limb cellulitis in 
humans in contact with raw fish (Koh et al., 2009). The presence of streptococcal pyrogenic 
exotoxin G gene (spegg) and streptolysin S structural gene (sagA), which have been associated 
with invasive disease in the exclusively human pathogen Streptococcus pyogenes (group A 
Streptococcus- GAS), has been documented in fish isolates of S. dysgalactiae subsp. 
dysgalactiae (Abdelsalam et al., 2010).  We have previously reported the presence of GAS 
phage-carried virulence genes among alpha-hemolytic S. dysgalactiae subsp. dysgalactiae 
isolates from bovine mastitis, namely, the streptococcal pyrogenic exotoxin genes speK, speC, 
speL, speM; the phage DNase1 gene spd1; and other genes encoding antimicrobial resistance 
determinants located on mobile genetic elements (MGEs) (see Chapter 4). So far, no more 
information is available regarding the presence of GAS virulence genes among S. dysgalactiae 
subsp. dysgalactiae strains, and nothing is known regarding the presence of GAS prophages in 
S. dysgalactiae subsp. dysgalactiae. However, the exchange of lysogenic phages among GAS 
and other human and animal species, particularly group C Streptococcus dysgalactiae subsp. 
equisimilis (a pathogen that colonizes and infects humans with a clinical spectrum of diseases 
resembling those caused by GAS), Streptococcus equi subsp. equi (exclusively horse pathogen) 
and S. equi subsp. zooepidemicus (a zoonotic pathogen) isolates, was previously reported 
(Vojtek et al., 2008, Holden et al., 2009). 
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The aim of the present work was to use a microarray of genes encoding GAS virulence factors 
(McMillan et al., 2007[a]) to have a better insight into the virulence gene pool (encoded or not 
by mobile genetic elements) shared between GAS and alpha-hemolytic S. dysgalactiae subsp. 
dysgalactiae isolates associated with bovine mastitis in comparison with beta-hemolytic S. 
dysgalactiae subsp. equisimilis isolates associated with human disease. 
 
4.2. Materials and Methods 
 
4.2.1. Bacterial isolates and identification 
 
A total of 18 alpha-hemolytic S. dysgalactiae subsp. dysgalactiae field isolates of Lancefield 
group C (GCS), one of the causative agents of bovine subclinical mastitis in dairy herds in 
Portugal, were used in the present study. For detailed information regarding these field isolates, 
including identification and molecular typing data see Chapter 2 and Chapter 4. In addition, six 
nonduplicated beta-hemolytic S. dysgalactiae subsp. equisimilis isolates of Lancefield group G 
(Group G Streptococcus [GGS]) (n = 5) and group C (GCS) (n = 1) collected in Portugal, 
causing pharyngitis (n = 5) and invasive disease (n = 1) in humans, were included in the study 
for the purpose of comparison. The identification of S. dysgalactiae subsp. equisimilis isolates 
was based on colony morphology, hemolysis in blood agar plates, and Lancefield grouping 
using the Streptex kit (Remel Europe Ltd, Dartford, England) and PCR amplification of the 16S 
rRNA gene and sequencing (Weisburg et al., 1991). 
We have included two GCS alpha-hemolytic S. dysgalactiae subsp. dysgalactiae invasive 
strains in the study, which were analyzed for the detection of selected virulence genes by PCR 
only (see below). One of these strains was associated with toxic shock-like syndrome in cattle 
(Chénier et al., 2008). The other strain caused ascending upper limb cellulitis in humans in 
contact with raw fish (Koh et al., 2009). The latter strain was previously identified (Koh et al., 
2009) by PCR amplification of the 16S rRNA and sodA genes and sequencing (GenBank 
accession numbers EU693902 and EU719068, respectively). We confirmed the identification of 
the strain associated with the toxic shock-like syndrome in cattle by PCR amplification of the 
16S rRNA (Weisburg et al., 1991) and of the sodA (Abdelsalam et al., 2010) genes and 
sequencing. Sequences were analyzed by using the BioEdit sequence alignment editor (Hall, 
1999) and compared with sequences from the National Center for Biotechnology Information 
(NCBI) database (Bethesda, MD) by using the BLAST alignment tool 
(www.ncbi.nlm.nih.gov/BLAST). 
The new sequences from the invasive S. dysgalactiae subsp. dysgalactiae strains were deposited 
in GenBank database (see Annex). 
  57
Chapter 4 
4.2.2. Pulsed-field gel electrophoresis (PFGE) profiles for clonal characterization 
 
A description of the bovine S. dysgalactiae subsp. dysgalactiae GCS field strains (n=18) 
including typing by PFGE was described in Chapter 4. The typing of the human S. dysgalactiae 
subsp. equisimilis GGS/GCS isolates (n = 6) by PFGE was carried out in this study as described 
for the bovine pathogen S. uberis (see Chapter 3). SmaI-digested DNA banding patterns 
obtained by PFGE were analyzed visually according to previously established criteria (Tenover 
et al., 1995). 
 
4.2.3. Microarray design and hybridization 
 
The microarray was described previously (McMillan et al., 2007[b]) and was used with minor 
modifications. In brief, the array consists of 70-mer oligonucleotides from the conserved 
regions of all ‘classical’ GAS virulence factors and orthologues of virulence factors found in 
other bacterial species as well as putative virulence genes present in the M1, M3, and M18 
genomes. In total, 220 virulence factor/extracellular protein genes, 10 housekeeping genes 
(positive controls), and 10 negative controls were randomly spotted in six locations on the chip. 
Genomic DNA was extracted using zirconicum beads in combination with the Qiagen DNeasy 
kit (Qiagen). Genomic DNA was partially digested with AluI, yielding fragments of between 
500 and 1,000 bp, and labeled with biotin. The labeled DNA was purified (PCR Purification 
Kit; Qiagen) and the labeling efficiency was verified by gel electrophoresis. Array hybridization 
was performed at 42°C for 16 h, followed by incubation with Streptavidin-Cy5 using a 
SlideBooster SB800 instrument (Advalytix). Fluorescence signals were obtained with a DNA 
Microarray Scanner (G2565CA; Agilent Technologies) at a 633-nm excitation wavelength and 
quantified by using ImaGene software (BioDiscovery). 
 
4.2.4. Microarray data processing 
 
The raw data were corrected for background and transformed to log scale. A two-component 
normal-mixture model (McLachlan & Peel, 2000) was fitted to the corrected data by a 
maximum likelihood method adapted from the mclust package (Fraley & Raftery, 2006). A 
discriminant function was calculated to represent the propensity of a gene for being present or 
absent. Discriminant values were stored in a signal probability matrix and colored for 
presentation purposes using the following scheme: black indicates state 0 (not present), green 
indicates state 1 (present), and yellow indicates indecisive measurement. 
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Microarray data accession number: Microarray data have been deposited in the public 
ArrayExpress database (http://www.ebi.ac.uk/arrayexpress/) under accession number E-MEXP-
3168.  
 
4.2.5. Confirmation of array data by PCR screening 
 
In order to confirm the results obtained with the GAS array, PCR was carried out on several 
genes (speH, speC, speA, speL, speK, speI, speM sdn, ssa, smeZ, sla, drs, prtf2, speG, ska, 
dppA, lbp, scpA, emm, isp, SpyM3_1736, slo, nga, spegg and sagA). The primer sequences, gene 
description, and amplification length of each reaction are described in Table 4.1. Samples 
without DNA and strains lacking (negative) or carrying (positive) specific genes were used as 
controls in the PCR. 
 
4.2.6. Sequence data and phylogenetic analysis of bacteriophage-associated virulence 
superantigen genes 
 
Sequences of the superantigen-encoding genes speC, speK, speL and speM of the bovine 
mastitis isolates under study, with high levels of identity among them, were chosen to generate 
an alignment of DNA sequences of the alleles of those genes and homologous sequences 
deposited in the NCBI database, in particular sequences of the speC, speK, speL and speM 
genes of S. pyogenes;  seeL and seeM genes of S. equi subsp. equi;  szeL and szeM genes of S. 
equi subsp. zooeepidemicus; and the sdm genev of S. dysgalactiae subsp. dysgalactiae.  
The alignment (380 bp) was used to construct a phylogenetic tree by using MEGA, version 4, 
software (Tamura et al., 2007). The p-distance parameter and neighbor-joining method were 
used. Bootstrap values were calculated from 1,000 replicates. Deduced amino acid sequences 
from these bovine alleles were compared with similar sequences from NCBI database by using 
the BLAST alignment tool (www.ncbi.nlm.nih.gov/BLAST). Sequencing was performed by 
STAB-Vida (Lisbon, Portugal) using the same primers used for amplification. Nucleotide 
sequences were analyzed by using the BioEdit sequence alignment editor (Hall, 1999). 
 
4.2.7. emm-typing 
 
Determination of emm gene (coding the M protein) types was performed as described by the 
CDC (http://www.cdc.gov/ncidod/biotech/strep/M-ProteinGene_typing.htm). 
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Gene 
description 
Primer target/ Primer sequence Product 
(bp) 
Source of 
reference 
Antiphagocytic 
M protein 
(chromosome) 
emm (for.) TATTCGCTTAGAAAATTAA 
emm (rev.) GCAAGTTCTTCAGCTTGTTT variable __
‡ 
Streptolysin S 
(chromosome) 
sagA (for.) TACTTCAAATATTTTAGCTACT 
sagA (rev.) GATGATACCCCGATAAGGATAA 487 
Abdelsalam 
et al., 2010 
Pyrogenic 
exotoxin H 
precursor 
(phage) 
speH (for.) AGATTGGATATCACAGG 
speH (rev.) CTATTCTCTCGTTATTGG 416 
Schmitz et 
al., 2003 
Pyrogenic 
exotoxin F 
(chromosome) 
speF (for.) TACTTGGATCAAGACG 
speF (rev.) GTAATTAATGGTGTAGCC 782 
Schmitz et 
al., 2003 
Pyrogenic 
exotoxin B 
(chromosome) 
speB (for.) TTCTAGGATACTCTACCAGC 
speB (rev.) ATTTGAGCAGTTGCAGTAGC 300 
Jasir et al., 
2001 
Pyrogenic 
exotoxin C 
precursor 
(phage) 
speC (for.) GCAGGGTAAATTTTTCAACGACACACA 
speC (rev.) TGTGCCAATTTCGATTCTGCCGC 407 This study 
Pyrogenic 
exotoxin A 
precursor 
(phage) 
speA (for.) ATGGAAAACAATAAAAAAGTATTG 
speA (rev.) TTACTTGGTTGTTAGGTAGACTTC 755 
Matsumoto 
et al., 2003 
Pyrogenic 
exotoxin L 
precursor 
(phage) 
speL (for.) CTGTTAGGATGGTTTCTGCGGAAGAG 
speL (rev.) AGCACCTTCCTCTTTCTCGCCT 605 This study 
Pyrogenic 
exotoxin K 
precursor 
(phage) 
speK (for.) 
TACAAATGATGTTAGAAATCCAAGGAACATATATGCT 
speK (rev.) 
CAAAGTGACTTACTTTACTCATATCAATCGTTTC 
656 
This study/ 
Lintges et 
al., 2007 
Pyrogenic 
exotoxin I 
precursor 
(phage) 
speI (for.) AATGAAGGTCCGCCATTTTC 
speI (rev.) TCTCTCTGTCACCATGTCCTG 516 
Matsumoto 
et al., 2003 
Pyrogenic 
exotoxin M 
precursor 
(phage) 
speM (for.) 
CCAATATGAAGATAACAAAGAAAATTGGCACCC 
speM (rev.) 
CAAAGTGACTTACTTTACTCATATCAATCGTTTC 
600 
This study/  
Lintges et 
al., 2007 
Pyrogenic 
exotoxin J 
(chromosome) 
speJ (for.) ATCTTTCATGGGTACG 
speJ (rev.) TTTCATGTTTATTGCC 535 
Schmitz et 
al., 2003 
Streptodornase 
(phage) 
sdn (for.) ACCCCATCGGAAGATAAAGC 
sdn (rev.) AACGTTCAACAGGCGCTTAC 489 
Matsumoto 
et al., 2003 
Streptococcal 
Dnase 1 (phage) 
spd1 (for.)  CCCTTCAGGATTGCTGTCAT 
spd1 (rev.) ACTGTTGACGCAGCTAGGG 400 
Green et 
al., 2005 
Streptococcal 
superantigen 
SSA (phage) 
ssa (for.)  TCCACAGGTCAGCTTTTACAG 
ssa (rev.)  TGATCAAATATTGCTCCAGGTG 502 
Matsumoto 
et al., 2003 
Table 4.1. Genes and PCR primers used for screening of virulence determinants among group C 
Streptococcus dysgalactiae subsp. dysgalactiae and group C and G Streptococcus dysgalactiae subsp. 
equisimilis isolates. 
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‡ http://www.cdc.gov/ncidod/biotech/strep/M-ProteinGene_typing.htm. 
 
 
Gene description Primer target/ Primer sequence Product 
(bp) 
Source of 
reference 
Phospholipase A2 (phage) sla (for.) CTCTAATAGCATCGGCTACGC sla (rev.) AATGGAAAATGGCACTGAAAG 440 
Matsumoto et 
al., 2003 
Mitogenic exotoxin Z 
(chromosome) 
smeZ (for.) 
CTTCAATATTCATTGCAATAATTTC 
smeZ (rev.) 
TGTAACTGTTGTTTTGTTAGTTGAT 
400 Provided by G. S. Chhatwal 
Pyrogenic exotoxin G of S. 
pyogenes (chromosome) 
speG (for.) 
TGTATCTTTAGGGATTACTGATCAG 
speG (rev.) 
CTCGACCTAAAAGCTTATCATCCTT 
389 This study 
Pyrogenic exotoxin G of S. 
dysgalactiae 
(chromosome) 
spegg (for.) 
GCTTATGATGTTACTCCACTTGA 
spegg (rev.) 
ATAACGCGATTCCGAATCATAGA 
420 This study 
Drs protein (chromosome) 
drs (for.) 
CAGCAGATGAAGCAAGTAATAGC 
drs (rev.) 
CTTGTTTGTCAATTTTGCTTTACGACC 
760 
Hartas & 
Sriprakash, 
1999 
Fibronectin binding protein 
Prtf1 (chromosome) 
prtf1 (for.)  
TATCAAAATCTTCTAAGTGCTGAG 
prtf1 (rev.)  
AATGGAACACTAACTTCGGACGGG 
930 Talay et al., 1994 
Fibronectin binding protein 
Prtf2 (chromosome) 
prtf2 (for.) ATAGGATTGTCCGGAGTATCA 
prtf2 (rev.)  TTATGTTGCTTCTCACCA 2,000 
Provided by G. 
S. Chhatwal 
Streptolysin O 
(chromosome) 
slo (for.) ACGGCAGCTCTTATCATT 
slo (rev.)  GACCTCAACCGTTGCTTTGT 600 
Provided by G. 
S. Chhatwal 
C5A peptidase precursor 
(transposon) 
scpA (for.) CCAAGACTTCAGCCACAAGG 
scpA (rev.) CAATTCCAGCCAATAGCAGC 591 
Provided by G. 
S. Chhatwal 
Streptokinase A precursor 
(chromosome) 
ska (for.)  CGATCAAAGGGATCATACGG 
ska (rev.)  AGGTTCACAGTAACGACGGC 598 
Provided by G. 
S. Chhatwal 
NAD-glycohydrolase 
precursor (chromosome) 
nga (for.) 
ATAACGGGAATAAATTGGTCCTC 
nga (rev.)  CGCTTTCTTTGTAGACTTGTTTT 
408 This study 
Laminin-binding protein 
(transposon) 
lmb (for.) AACCCCAAACAGCCTACGCAAG 
lmb (rev.) 
TAAAACGGGATCCGTCCAGGTAT 
375 This study 
Immunogenic secreted 
protein (chromosome) 
isp (for.) CAACTGAAAAAACCCCAGAGCC 
isp (rev.) 
GGTTGAAGTCAAAGGCACCATAA 
429 This study 
Surface lipoprotein DppA  
(chromosome) 
dppA (for.) 
CCGTTATGGAGTCCACAATGAA 
dppA (rev.) 
ACTAGCTTTGAGTTTAATAGTAATC 
1,045 This study 
Putative ATB-binding 
cassette transporter protein 
(chromosome) 
SpyM3_1736 (for.) 
GAGAAGTCAAAGAGGTCTTTGTT 
SpyM3_1736  (rev.)  
GGTGTCATACTCTAGTTTACCTTT 
392 This study 
Table 4.1.  -Continued 
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4.2.8. Gene expression assays by reverse-transcriptase PCR (RT-PCR) 
  
For RNA extraction, all isolates were grown in Todd-Hewitt broth (Oxoid Limited, 
Basingstoke, England) supplemented with 1% yeast extract (BD, Franklin Lakes) (THY) at 
37ºC until the mid-exponential phase was reached (optical density [OD] at 600 nm of 0.5), and 
the NucleoSpin RNAII kit (Macherey-Nagel, Dueren, Germany) was used according to the 
manufacturer’s instructions, followed by the addition of 2U/L of DnaseI (Applied 
Biosystems/Ambion). RNA quality was confirmed by 1% agarose gel electrophoresis, and 
images were captured by using the Gel Doc XR system and Quantity One 1-D analysis software 
(Bio-Rad). To confirm that no remaining DNA was present in RNA samples, PCR assays were 
performed targeting the housekeeping genes rpsL and rpsB and the genes under study, speM, 
speK, speL, speC, spd1, sdn, slo scpA, ska, nga, lmb, isp, dppA, emm and SpyM3_1736, using 
RNA as a template. Reverse transcriptase (RT) reactions for cDNA synthesis were performed 
by using the SuperScript First-Strand Synthesis System for RT-PCR kit (Invitrogen, New 
Zealand). PCR targeting those genes under study was carried out again using by using cDNA as 
a template. 
 
4.2.9. Growth curve analysis 
 
In order to ascertain if growth curves (using the same media and conditions of growth) of six of 
the bovine mastitis GCS S. dysgalactiae subsp. dysgalactiae isolates from the present study 
(chosen according to their genotype) were comparable or not, an automated growth curve 
analysis system (BioScreen C, Piscataway, NJ) was used as described previously (Carlos et al., 
2009). Briefly, these isolates were grown overnight in THY, and cells were centrifuged in order 
to collect 109 CFU in the pellet. After re-suspended and washed in Phosphate Buffered Saline- 
PBS (10 mM, pH 7.0), the pellet was resuspended in 100 μl of PBS, and 1% (vol/vol) of this 
bacterial suspension was used to inoculate each of the wells of the BioScreen plaque containing 
growth media. Three different growth media were tested: THY, bovine blood serum 
(Probiologica), and bovine milk serum freshly prepared in the laboratory as previously 
described (Melchior et al., 2009). The growth media were prepared at different pHs (6.0, 6.6, 
and 7.4), and three different incubation temperatures (37ºC, 38ºC, and 40ºC) were tested for 
each growth media, which represent different environmental conditions in the bovine udder 
(e.g., the body temperature of a healthy cow is around 38ºC, which may rise to 40ºC during a 
mastitis infection). 
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4.2.10. Virulence gene profiling of invasive Streptococcus dysgalactiae subsp. 
dysgalactiae 
 
Eighteen virulence genes (sagA, sla, sdn, spd1, speI, speC, speA, speB, speK, speF, speM, speH, 
speL, speJ, ssa, smeZ, spegg, and prtf1) were searched for by PCR (see Table 4.1) in the two 
invasive GCS strains that were included in the study. 
 
4.3. Results 
 
4.3.1. Identification by 16S rDNA and sodA genes sequence analyses 
 
The identification of the bovine mastitis S. dysgalactiae subsp. dysgalactiae isolates was 
confirmed in a previous work using the 16S rRNA gene sequencing (see Chapter 4). The 16S 
rRNA gene sequences of all human GCS/GGS isolates from the present study showed 99-100% 
identity to 16S rRNA gene sequences of S. dysgalactiae subsp. equisimilis deposited in the 
NCBI database. Taking into account the phenotypic characteristics of the isolates together with 
the 16S rRNA gene sequence analysis, we could confirm the six human beta-hemolytic 
GGS/GCS isolates included in this study as being S. dysgalactiae subsp. equisimilis isolates. 
The 16S rRNA and sodA gene sequences of the GCS strain associated with the toxic shock-like 
syndrome in cattle were deposited in the GenBank database (accession numbers JF789447 and 
JF789445, respectively), whereas the same above-mentioned sequences of the GCS strain 
isolated from a case of ascending upper limb cellulitis in humans were already available 
(accession numbers EU693902 and EU719068, respectively), as described previously (Koh et 
al., 2009). Both 16S rRNA and sodA gene sequences of these two strains showed 99 to 100% 
identity with S. dysgalactiae subsp. dysgalactiae 16S rRNA and sodA gene sequences available 
for comparison in the NCBI database. 
 
4.3.2. PFGE profiles 
 
The 18 bovine S. dysgalactiae subsp. dysgalactiae isolates had 15 PFGE patterns, as shown in 
Fig. 3.1 (see Chapter 3). The six S. dysgalactiae subsp. equisimilis isolates had six different 
PFGE patterns with more than six band differences and were therefore considered unrelated 
according to established criteria (Tenover et al., 1995). 
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4.3.3. emm-typing 
 
None of the 18 alpha-hemolytic group C S. dysgalactiae subsp. dysgalactiae bovine isolates 
were typed by emm-typing, since no amplification for this gene could be obtained. The emm 
gene types of the six human S. dysgalactiae subsp. equisimilis isolates were as follows: stC839 
(GCS isolate; n = 1), stG485, stG480, stG6792, and stG4831 (GGS isolates; n = 5). 
 
4.3.4. Microarray data 
 
Of the 220 GAS virulence genes on the array (McMillan et al., 2007[b]), 44 genes (20%) were 
present in all bovine mastitis GCS (S. dysgalactiae subsp. dysgalactiae) and in all human 
GGS/GCS (S. dysgalatiae subsp. equisimilis) isolates, whereas 66 genes (30%) were not present 
in any of the isolates tested. The remaining genes (50%) showed variable distributions among 
isolates of both origins. Relevant genes present in at least one isolate (bovine or human) and 
genes present in all the bovine isolates (with exception of hypothetical proteins) are shown in 
Table 4.2. Nine genes (ska, dppA, lmb, scpA, emm, isp, nga, slo, and SpyM3_1736) were 
present in all the human isolates and absent in the bovine isolates, whereas only one gene 
(SpyM3_0345), encoding an uncharacterized protein, was detected in all bovine isolates and 
absent in all human isolates. 
If we restrict the comparison to bacteriophage genes on the array, we observed that 65% of the 
phage-related genes were present in at least one bovine GCS isolate, whereas 35% were 
detected in at least one human GCS/GGS isolate. None of the 13 bacteriophage-harbored 
virulence genes speC, speJ, speI, speH, ssa, mf4, slaA, speA3, speK, speL, speM, spd1, and sdn 
were detected in human GGS/GCS S. dysgalactiae subsp. equisimilis isolates, whereas at least 
one of the following six genes speC, speK, speL, speM, spd1, and sdn was detected in 72% (n = 
13) of the bovine mastitis GCS S. dysgalactiae subsp. dysgalactiae isolates. 
Other GAS genes on the array, located in variable and recombinatory loci of the GAS genomes 
(McMillan et al., 2007[a]; McMillan et al., 2007[b]), were detected in both human and bovine 
isolates. These include the Spy2009 gene, encoding a transposase (Sumby et al., 2005), and sic 
(at the mga chromosomal location); the spyM18_2055 gene, coding for an amidase (at the spa 
chromosomal location); malE (at the maltose chromosomal location); prtF15 and sfbI (at the 
fibronectin-collagen-T antigen [FCT]-encoding region); citE (at the cit chromosomal location); 
and epf (at the sagA chromosomal location). The gene coding for the adhesin R28 carried by a 
putative integrative conjugative element was present in all bovine and human isolates. 
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Distribution (%) (no. of isolates) 
Human Group A Streptococcus pyogenes 
virulence class protein (gene) 
Bovine Group C 
Streptococcus 
dysgalactiae subsp. 
dysgalactiae (n = 18) 
Human Group C/G 
Streptococcus 
dysgalactiae subsp. 
equisimilis (n = 6) 
Adhesins   
Antiphagocytic M protein (emm) 0 (n=0) 100 (n=6) 
Laminin-binding protein (lmb)a 0 (n=0) 100 (n=6) 
Collagen-like surface protein (scl)a 89 (n=16) 100 (n=6) 
PAM 94 (n=17) 100 (n=6) 
Putative adhesion protein (adcA) 94 (n=17) 100 (n=6) 
Putative extracellular matrix binding protein 
(epf)a 94 (n=17) 100 (n=6) 
Putative pullulanase (pulA) 94 (n=17) 83 (n=5) 
Collagen-like protein SclB (sclB) 100 (n=18) 100 (n=6) 
Glyceraldehyde-3-phosphate dehydrogenase 
(plr) 100 (n=18) 83 (n=5) 
R28a 100 (n=18) 100 (n=6) 
Putative choline binding protein 
(SpyM3_0025) 100 (n=18) 100 (n=6) 
Putative collagen-like protein (Spy1054) 100 (n=18) 100 (n=6) 
Putative enolase (eno) 100 (n=18) 100 (n=6) 
Putative internalin A precursor (inlA) 100 (n=18) 100 (n=6) 
   
Fibronectin-binding proteins   
SfbX 6 (n=1) 17 (n=1) 
SfbIa 89 (n=16) 100 (n=6) 
PrtF15a 100 (n=18) 100 (n=6) 
Putative fibronectin-binding protein-like 
protein A (SpyM3_0652) 100 (n=18) 67 (n=4) 
   
Proteases   
C5A peptidase precursor (scpA)a 0 (n=0) 100 (n=6) 
Putative C3-degrading proteinase (cppA) 22 (n=4) 0 (n=0) 
Putative exfoliative toxin (SpyM3_0632) 94 (n=17) 67 (n=4) 
Putative serine protease (degP) 94 (n=17) 100 (n=6) 
Putative protease (SpyM3_0418) 100 (n=18) 100 (n=6) 
   
Toxins   
Streptolysin O (slo) 0 (n=0) 100 (n=6) 
Putative hemolysin III (hlyIII) 83 (n=15) 100 (n=6) 
Putative hemolysin (hlyX) 94 (n=17) 100 (n=6) 
Streptolysin S-associated protein (sagA) 100 (n=18) 100 (n=6) 
Putative DNA-entry nuclease (endA) 100 (n=18) 100 (n=6) 
Putative hemolysin (hlyA) 100 (n=18) 100 (n=6) 
   
Other virulence factors   
Dipeptide permease complex (dppA) 0 (n=0) 100 (n=6) 
Immunogenic secreted protein precursor (isp) 0 (n=0) 100 (n=6) 
Inhibitor of complement-mediated lysis (sic) 0 (n=0) 50 (n=3) 
Continued on following page 
 
 
Table 4.2. Distribution of group A Streptococcus virulence factors of the array in bovine mastitis group C 
Streptococcus dysgalactiae subsp. dysgalactiae isolates and human non-invasive and invasive group C 
and G Streptococcus dysgalactiae subsp. equisimilis isolates†. 
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Distribution (%) (no. of isolates) 
Human Group A Streptococcus pyogenes 
virulence class protein (gene) 
Bovine Group C 
Streptococcus 
dysgalactiae subsp. 
dysgalactiae (n = 18) 
Human Group C/G 
Streptococcus 
dysgalactiae subsp. 
equisimilis (n = 6) 
Other virulence factors (continued)   
NAD-glycohydrolase (nga) 0 (n=0) 100 (n=6) 
Pyrogenic exotoxin G precursor (speG) 0 (n=0) 83 (n=5) 
Streptokinase A precursor (ska) 0 (n=0) 100 (n=6) 
Transposase (spy2009)a 22 (n=4) 83 (n=5) 
Putative hyaluronidase (hyl) 28 (n=5) 100 (n=6) 
Putative 6-phospho-beta-galactosidase (lacG) 39 (n=7) 0 (n=0) 
Immunogenic secreted protein precursor 
homologue (isp.2) 67 (n=12) 100 (n=6) 
Extracellular hyaluronate lyase (hylA) 78 (n=14) 50 (n=3) 
Streptococcal protective antigen (spa) 78 (n=14) 50 (n=3) 
Putative penicillin-binding protein 1A 
(pbp1A) 83 (n=15) 33 (n=2) 
Putative glutathione peroxidise 
(SpyM3_0428) 89 (n=16) 100 (n=6) 
Putative GTP-binding protein LepA (lepA) 89 (n=16) 100 (n=6) 
Arginine deiminase (arcA) 100 (n=18) 100 (n=6) 
Maltose/maltodextrin-binding protein 
(malE)a 100 (n=18) 100 (n=6) 
67 kDa myosin-cross-reactive streptococcal 
antigen (SpyM3_0332) 100 (n=18) 100 (n=6) 
Putative acid phosphatase (lppC) 100 (n=18) 100 (n=6) 
Putative amidase (SpyM18_2055)a 100 (n=18) 100 (n=6) 
Putative carbamate kinase (arcC) 100 (n=18) 100 (n=6) 
Putative citrate lyase beta subunit (citE)a 100 (n=18) 50 (n=3) 
Putative cytoplasmic membrane protein 
(lemA) 100 (n=18) 100 (n=6) 
Putative dipeptidase (pepD) 100 (n=18) 100 (n=6) 
Putative dipeptidase (SpyM3_1763) 100 (n=18) 100 (n=6) 
Putative ferric uptake regulator (spf) 100 (n=18) 100 (n=6) 
Putative fructose-1-phosphate kinase (fruK) 100 (n=18) 100 (n=6) 
Putative lipoprotein (atmB) 100 (n=18) 100 (n=6) 
Putative manganese-dependent inorganic 
pyrophosphatase (SpyM3_0278) 100 (n=18) 100 (n=6) 
Putative metal binding protein of ABC 
transporter (mtsA) 100 (n=18) 100 (n=6) 
Putative peptidyl-prolyl cis-trans isomerase 
(cypB) 100 (n=18) 100 (n=6) 
Putative protease maturation protein (prsA) 100 (n=18) 50 (n=3) 
Putative proton-translocating ATPase subunit 
b (SpyM3_0495) 100 (n=18) 100 (n=6) 
Putative PTS system IIB component 
(SpyM3_1679) 100 (n=18) 100 (n=6) 
Putative sugar transporter sugar binding 
lipoprotein 100 (n=18) 100 (n=6) 
Putative two-component sensor histidine 
kinase (yesM) 100 (n=18) 100 (n=6) 
Putative uridine kinase (udk) 100 (n=18) 100 (n=6) 
Continued on following page 
 
Table 4.2.  -Continued 
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Distribution (%) (no. of isolates) 
Human Group A Streptococcus pyogenes 
virulence class protein (gene) 
Bovine Group C 
Streptococcus 
dysgalactiae subsp. 
dysgalactiae (n = 18) 
Human Group C/G 
Streptococcus 
dysgalactiae subsp. 
equisimilis (n = 6) 
Bacteriophage-encoded recognized virulence 
factors   
Streptodornase, phage associated (sdn) 22 (n=4) 0 (n=0) 
Putative exotoxin L precursor, phage 
associated (speL) 22 (n=4) 0 (n=0) 
Pyrogenic exotoxin C precursor, phage 
associated (speC) 33 (n=6) 0 (n=0) 
Putative DNase, phage associated (spd1) 33 (n=6) 0 (n=0) 
Streptococcal pyrogenic K exotoxin, phage 
associated (speK) 50 (n=9) 0 (n=0) 
Putative exotoxin M precursor, phage 
associated (speM) 56 (n=10) 0 (n=0) 
   
Other bacteriophage-encoded factors   
Putative deoxyribonuclease 33 (n=6) 50 (n=3) 
Putative lysine, phage associated 89 (n=16) 100 (n=6) 
hypothetical phage protein 100 (n=18) 100 (n=6) 
Putative endolysin, phage associated 100 (n=18) 100 (n=6) 
   
 
aGenes associated with lateral gene transfer (non-bacteriophage related). 
†Only genes present in at least one isolate (bovine or human) and genes present in all bovine group C 
Streptococcus dysgalactiae subsp. dysgalactiae isolates are listed. 
Hypothetical proteins are not listed in the Table. 
 
 
4.3.5. Confirmation of array data by PCR screening 
 
All PCR results confirmed the GAS microarray data (Table 4.2), except for speM, speK, and 
speG genes.  The speM and speK genes share high levels of identity among their DNA 
sequences, which resulted in false-positive results by the array data. In addition, it was not clear 
how many isolates carried the speG gene by both the array and PCR amplification results.By 
using other primers (designed in this study) targeting the speM and speK genes of S. pyogenes 
and spegg of S. dysgalactiae subsp. equisimilis (Zhao et al., 2007), eight bovine isolates that 
carried speK, one bovine isolate that carried speM, one bovine isolate that carried speK and 
speM, and five human isolates that carried  spegg were found. 
 
4.3.6. Sequence data and phylogenetic analysis of bacteriophage-associated virulence 
superantigen genes 
 
Table 4.2.  -Continued 
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Three speK alleles (speK-1Bov, speK-2Bov, and speK-3Bov) were identified among nine bovine 
isolates, two speM alleles (speM-1Bov, and speM-2Bov), were identified in two bovine isolates, 
one speC allele (speCBov) was identified in six bovine isolates, and one speL allele (speLBov) was 
identified in four bovine isolates (GenBank accession numbers HQ724300 to HQ724305 and 
HQ696925). The phylogenetic tree based on sequences of those alleles and of homologous 
sequences available in the NCBI database showed four major groups, each one comprising one 
of the four spe genes (speK, speM, speC, or speL) of bovine S. dysgalactiae subsp. dysgalactiae 
isolates and of S. pyogenes, as shown in Fig. 4.1. The tree also shows that speM and speK 
diverged more recently, as these two groups showed higher identities among them than with the 
speL or speC groups.  
Amino acid sequences deduced from the bovine GCS alleles always showed 98 to 99% identity 
with the homologous GAS pyrogenic exotoxins gene sequences from the NCBI database, with 
the exception of bovine SpeL, which showed higher level of identity with SeeM from S. equi 
subsp. equi (99%) than with SpeL from S. pyogenes (96%). In particular, and interestingly, 
SpeM from bovine isolates in the present study showed 99% identity with SpeM from GAS and 
100% identity with Sdm from S. dysgalactiae subsp. dysgalactiae (sequences deposited in 
NCBI database).  
The new alleles from the bovine S. dysgalactiae subsp. dysgalactiae isolates were deposited in 
GenBank database (see Annex). 
 
4.3.7. Gene expression assays by RT-PCR 
 
Transcriptional analysis revealed that the bacteriophage-associated virulence genes speM, speK, 
speL, speC, spd1, and sdn, detected in bovine GCS isolates, were transcribed and that the 
virulence genes ska, dppA, lmb, scpA, emm, isp, SpyM3_1736, slo, and nga, detected only in 
human isolates, were also transcribed. 
 
4.3.8. Growth curve analysis 
 
In the present study all the strains under analysis by BioScreen reached the highest OD values 
when grown in the bovine blood serum media (compared to those when grown in THY and 
bovine milk serum) and under infection-related conditions (at 40ºC), with the end of the 
exponential phase achieved relatively fast (prior to 5 h of incubation). In bovine milk serum, the 
end of the exponential phase was achieved in most cases after 10 h of incubation, whereas in 
THY, growth curves reached the end of the exponential phase prior to 10 h of growth, followed 
by long stationary phases (no OD decrease was observed during 30 h or more of growth). 
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speK-1BOV (HQ724300) 
 speK-3BOV (HQ72302) 
 speK-2BOV (HQ724301) 
seeL - SESE (AJ583527)  
speK - GAS (3573931) 
szeL - SESZ (AJ851369)  
speM - GAS(993646) 
 speM-2BOV (HQ724305) 
 speM-1BOV (HQ724304) 
sdm - SDSD (AB074529)  
speL - GAS (994087) 
 speLBOV (HQ724303) 
seeM - SESE (AJ583528 ) 
szeM - SESZ (AJ851826 ) 
 speCBOV (HQ696925) 
 speC - GAS (993580) 
speC - GAS (900896) 
 speC - GAS (2942378) 90
61
100
91
90
100
99
100
100 
53
55 
100
57
65
0.05 
Polymorphic sites: 4
Polymorphic sites: 10
Polymorphic sites: 6 
Polymorphic sites: 4
Furthermore, we have observed differences in growth curves among isolates from the present 
study, suggesting a strain-specific mode of growth. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.3.9. Virulence gene profiling of invasive Streptococcus dysgalactiae subsp. 
dysgalactiae 
 
Both strains were negative for all the genes tested (n = 18) by PCR, with the exception of the 
sagA gene. According to the sequences available in the NCBI database, the sagA of the animal 
strain (GenBank accession number JF789442) showed 95% identity either with the sagA gene 
of S. dysgalactiae subsp. dysgalactiae or with that of S. dysgalactiae subsp. equisimilis. In 
Fig. 4.1. Phylogenetic analysis of superantigen gene sequences of bovine group C Streptococcus from the 
present study and of sequences of S. pyogenes, S. equi subsp. equi, S. equi subsp. zooepidemicus, and S. 
dysgalactiae subsp. dysgalactiae available in the National Center for Biotechnology Information (NCBI) 
(Bethesda, MD) database. Bovine group C Streptococcus sequences from the present study are designated 
in the tree in boldface type. Other sequences are designated as follows: SESE, S. equi subsp. equi (seeL 
and seeM); SESZ, S. equi subsp. zooepidemicus (szeL and szeM); SDSD, S. dysgalactiae subsp. 
dysgalactiae (sdm); GAS, S. pyogenes (speK, speM, speL, and speC). GenBank accession numbers (for 
bovine alleles, seeL, seeM, szeL, szeM, and sdm) and gene ID numbers (for GAS speK, speM, speL, and 
speC) are included in parentheses after the gene names. 
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parallel, the sagA gene of the human strain (accession number JF789443) was 100% identical to 
the sagA gene of S. dysgalactiae subsp. dysgalactiae and 99% identical to the sagA gene of S. 
dysgalactiae subsp. equisimilis. 
The new sequences from the invasive S. dysgalactiae subsp. dysgalactiae strains were deposited 
in GenBank database (see Annex). 
 
4.4. Discussion 
 
4.4.1. Assessment of genes associated with MGEs among Streptococcus dysgalactiae 
subsp. dysgalactiae and Streptococcus dysgalactiae equisilimis 
 
An array containing 220 virulence genes from S. pyogenes (group A Streptococcus [GAS]) was 
used to analyze the virulence gene pool among S. dysgalactiae subsp. dysgalactiae (group C 
Streptococcus [GCS]) strains, associated with bovine mastitis, and among S. dysgalactiae subsp. 
equisilimis (group C or group G Streptococcus [GCS/GGS]) isolates, associated with human 
pharyngitis and invasive disease episodes. We previously reported the presence of GAS 
virulence genes in bovine GCS isolates (see Chapter 4), which motivated us to further analyze 
the bovine strains in a search for the presence of other GAS virulence genes (either 
chromosomal or encoded by mobile genetic elements). The genes included in the array used in 
this study are from M1, M3, and M18 GAS genomes, of which M1 and M3 in particular are 
usually associated with severe disease in Europe and North America (Luca-Harari et al., 2009; 
Sierig et al., 2003). The results showed that the genes were unevenly distributed among isolates 
of different host origins. The bovine GCS and GAS shared 23% of all genes, and both the 
human GCS/GGS and GAS shared 39% of all genes. A higher content of GAS virulence genes 
in human GGC/GGS was expected, since both species share the same tissue niche in humans 
and cause similar spectra of diseases (Davies et al., 2009; Igwe et al., 2003; Takahashi et al., 
2010). Nevertheless, and most interestingly, none of the 13 bacteriophage virulence-related 
genes, all associated with GAS disease, were detected in the human GCS/GGS isolates. 
However, 6 of those 13 genes were detected in the bovine GCS isolates, and we have observed 
that these GAS phage-related genes (speK, speL, speM, speC, spd1, and sdn) present in bovine 
GCS are expressed in vitro, suggesting that bacteriophages may also play a role in the genetic 
plasticity and virulence of bovine mastitis GCS S. dysgalactiae subsp. dysgalactiae isolates. 
Specifically, the distribution of genes among the bovine GCS ranged from one phage-related 
gene (sdn) present in three isolates to five genes (speC-speK-speL-speM-spd1) present in one 
isolate. Also, the observed linkage of genes in a same bovine GBS strain, in particular speC-
spd1 (from the M1 phage), speM-speL (from the M18 phage) and speK (from the M3 phage), 
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indicates polylysogeny, similarly to what was described previously for GAS (Beres & Musser, 
2007). However, the lack of an association of sets of genes carried by complete phage genomes 
in our bovine isolates strongly suggests a recombinatory mosaic nature of phages, as observed 
previously for GAS (Beres & Musser, 2007). 
Also interesting was the observation that “non-bacteriophage associated” genes previously 
shown to be located in recombinatorial and mutational hotspots of the GAS genome and thus 
considered to be associated with lateral gene transfer (McMillan et al., 2007[a]; McMillan et al., 
2007[b]), were detected in both the bovine GCS and human GCS/GGS isolates from the present 
study (see Table 4.2). These genes (such as prtf15, epf, citE, and sic) belong to four of the five 
large chromosomal regions described previously to have variable loci in the GAS genome 
(McMillan et al., 2007[b]). One of the chromosomal regions includes the FCT locus (Towers et 
al., 2004), which is considered one of the major location of adhesins in GAS. Another 
chromosomal region is sagA, whereas another region includes the maltose transport and cit 
operons. The fourth region includes the mga and spa loci. 
Furthermore, the gene encoding the cell surface-anchored adhesin R28, carried by a putative 
integrative conjugative elements in GAS which resemble genetic elements of Group B 
Streptococcus agalactiae (GBS) (Stalhammar-Carlemalm et al., 1999) was detected in all 
bovine and human isolates. Also, the C5a peptidase precursor scpA gene as well as the lbp gene, 
encoding the laminin-binding protein, both known to be carried by a composite transposon of 
GBS (Franken et al., 2001), were detected in all human isolates and not in bovine isolates. 
Together, our data highlight the importance of MGEs mediating lateral gene transfer among 
different streptococcal species, including bovine GCS. 
 
4.4.2. Nonrandom distribution of GAS virulence genes in bovine mastitis GCS isolates 
 
Genes of GAS encoding adhesins, such as glyceraldehyde-3-phosphate dehydrogenase, a 
putative enolase, PrtF15, R28, a putative internalin A precursor, and putative fibronectin-
binding protein-like protein A (Brassard et al., 2004; Cork et al., 2009; Katerov et al., 1998; 
Stalhammar-Carlemalm et al., 1999; Waldemarsson et al., 2006), detected in all bovine GCS S. 
dysgalactiae subsp. dysgalactiae isolates, strongly suggest that these might represent important 
virulence factors in this particular subspecies. In particular, the emm gene, encoding the 
antiphagocytic M protein, was not present in the bovine isolates, although 94% of these isolates 
carried the gene encoding PAM, a member of the M protein family. 
Also interestingly, streptolysin S, strongly associated with invasive disease caused by GAS and 
associated with the beta-hemolytic phenotype of GAS and GCS/GGS (S. dysgalactiae subsp. 
equisimilis) (Betschel et al., 1998; Humar et al., 2002), was detected in all bovine isolates, 
  71
Chapter 4 
which are alpha-hemolytic (a sequence of this gene from one of the bovine mastitis isolates was 
deposited in GenBank under accession number JF789444). Furthermore, the presence of the 
streptolysin S gene (sagA) in alpha-hemolytic strains of group G (S. dysgalactiae subsp. 
equisimilis) and group C (S. dysgalactiae subsp. dysgalactiae) streptococci, from human and 
animal origins, respectively, was reported previously (Abdelsalam et al., 2010; Woo et al., 
2003). 
Bovine GCS is known to grow well in mammary secretions, either during lactation or from dry 
animals (Oliver, 1991; Song et al., 2005), which may be necessary to survival and establishment 
in the specific environmental niche that is the bovine mammary gland. The results obtained in 
the present study by using the BioScreen suggest environmental adaptability of the bovine GCS 
strains, which demonstrated the ability to grow fast in bovine blood serum and also, although 
with lower levels of growth, in the remaining tested media (THY and bovine milk serum). 
GAS genes related to housekeeping functions were also detected in the bovine isolates from the 
present study, such as arginine deiminase, a putative metal-binding protein of the ABC 
transporter, a putative phosphotransferase system (PTS) IIB component, maltose/maltodextrin-
binding protein, and putative ferric uptake regulator (Casiano-Colón & Marquis, 1988; Lei et 
al., 2003; Lortie et al., 2000; Shelburne et al., 2009; Ricci et al., 2002). 
The gene encoding 6-phospho-beta-galactosidase, an enzyme of the glycoside hydrolase family 
1 (Cantarel et al., 2008) associated with the capacity of carbohydrate utilization, was detected in 
only 39% of the bovine isolates (and absent in all human isolates). We have observed 
differences in growth curves among isolates from the present study, which do not seem to 
correlate with the presence/absence of the 6-phospho-beta-galactosidase gene. Variable growth 
pattern of strains in bovine mammary secretions were previously described (Oliver, 1991) and 
may be related with the presence or absence of genes associated with the capacity for 
carbohydrate utilization but probably not of this particular gene. 
 
4.4.3. Virulence genes detected only in the human GCS/GGS isolates 
 
In epidemiologically and genetically unrelated S. dysgalactiae subsp. equisimilis strains from 
human disease (pharyngitis and invasive), we detected nine genes that were not detected in the 
bovine isolates. Out of these nine genes, five were previously described for human S. 
dysgalactiae subsp. equisimilis: lbp (encoding the adhesion Lmb, a laminin-binding protein) 
(Terao et al., 2002), ska (encoding the plasminogen-activating Ska-streptokinase A protein) 
(McArthur et al., 2008), slo (encoding the cytolytic streptolysin O toxin) (Sierig et al., 2003), 
emm (encoding the M protein), as well as scpA (encoding a C5a peptidase), with the latter two 
genes acting on the complement pathway of the host, inhibiting bacterial opsonization and 
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phagocytosis (Hollingshead et al., 1986; Chen & Cleary, 1990). Both the lbp and scpA genes 
have been found in human GBS isolates and are usually absent in bovine GBS isolates (Gleich-
Theurer et al., 2009). These latter two genes and also ska are known to be carried by a bovine 
pathogen, S. uberis, although Lmb is not required for attachment of S. uberis to host epithelial 
cells, and the Ska locus is devoid of plasminogen activator coding sequences (Ward et al., 
2009). The four remaining genes were found for the first time, in our study, in human 
dysgalactiae subsp. equisimilis isolates: the nga gene (encoding a GAS extracellular enzyme 
NAD-glycohydrolase), associated with cytotoxicity in host cells (Madden et al., 2001); the isp 
gene (encoding an immunogenic secreted protein), which has an unknown function, although it 
is known to be expressed by GAS in the human host and generates antibody responses (McIver 
et al., 1998); the dppA gene (encoding a dipeptide permease complex), which is a membrane-
associated transporter for dipeptides in GAS and is regulated by the multigene transcriptional 
regulator Mga (Podbielski et al., 1998); and the SpyM3_ 1736 gene (coding for a putative ABC 
transporter protein). By gene expression assays (RT-PCR), we observed that all these nine genes 
from GAS isolates were expressed in human GCS/GGS isolates. 
These observations together with the absence of these nine genes in the bovine GCS isolates 
from this study suggest that they may be more important in human host streptococci than in 
animal host streptococci. 
 
4.4.4. Sequence data and phylogenetic analysis of superantigen genes of bovine group 
C S. dysgalactiae subsp. dysgalactiae 
 
The bovine alleles were distributed by the four clades according to the S. pyogenes alleles (Fig. 
4.1). In the speK clade, the bovine alleles are organized together and separately from the seeL 
and szeL genes of S. equi subsp. equi and S. equi subsp. zooepidemicus and the speK gene of S. 
pyogenes, which was expected, since the streptococcal pathogens S. equi subsp. equi, S. equi 
subsp. zooepidemicus, and S. pyogenes are known to share a phage pool (Holden et al., 2009). 
In contrast, within the speL clade, the sequences of the seeM and szeM genes of S. equi subsp. 
equi and S. equi subsp. zooepidemicus, respectively, were organized closer to the bovine speLBov 
allele from the present study and separately to the speL sequence of S. pyogenes, suggesting a 
common phage content among the animal species. Also, considering the speC clade, we may 
speculate that the same or a similar phage(s) is shared between bovine S. dysgalactiae subsp. 
dysgalactiae and human S. pyogenes. 
The reason why the seeL and szeL sequences were not located in the speL clade and the seeM 
and szeM sequences were not in the speM clade may be due to incorrect nomenclature given to 
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these genes of S. equi subsp. equi and S. equi subsp. zooepidemicus. Therefore, seeL and szeL 
should be named seeK and szeK, whereas szeM and seeM should be named as seeL and szeL. 
The bovine GCS SpeM amino acid sequence (with a length of 177 amino acid residues) showed 
100% identity with S. dysgalactiae-derived mitogen (Sdm) sequence available in the NCBI 
database. Sdm (encoded by the sdm gene) was the only superantigen with mitogenic activity 
described so far for S. dysgalactiae subsp. dysgalactiae (Miyoshi-Akiyama et al., 2003). In 
agreement with our findings, the authors of that study (Miyoshi-Akiyama et al., 2003) also 
noticed high levels of identity between sdm (from S. dysgalactiae subsp. dysgalactiae) and 
speM of S. pyogenes. sdm and speM are probably the same gene, with different nomenclatures. 
Our findings underline the role of GAS phages (which are known to be shared with S. equi 
subsp. equi and S. equi subsp. zooepidemicus) in the genetic diversity of bovine S. dysgalactiae 
subsp. dysgalactiae strains. Additionally, it would be of interest to further search for the 
presence and expression of virulence factors not represented on the array, which can be either 
present or not in the genomes of the strains tested. Since several genome sequences of 
streptococcal species are available, whole-genome and transcriptome comparisons using a pair 
of S. dysgalactiae subsp. dysgalactiae strains described in the present study (the putative 
zoonotic strain and the bovine mastitis strain with a large pool of GAS virulence phage-related 
genes) would certainly give further insights into the genomic plasticity of this pathogenic 
subspecies. 
 
4.5. Conclusions 
 
In conclusion, the presence of GAS virulence genes, particularly genes encoded by MGEs, 
either randomly or nonrandomly distributed among strains of bovine GCS may contribute to the 
increased virulence potential of these strains, namely, the possibility of dissemination to 
different tissues of the host and to take advantage of new niches. As we have pointed out 
previously, S. dysgalactiae subsp. dysgalactiae should not be disregarded as an infection agent 
in humans. In fact, this subspecies was associated with invasive disease in humans (Koh et al., 
2009) and here was shown to carry the S. pyogenes streptolysin S gene, further suggesting that 
S. dysgalactiae subsp. dysgalactiae is an emerging zoonotic pathogen. 
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Abstract  
 
Streptococcus agalactiae (Group B Streptococcus, GBS), Streptococcus dysgalactiae subsp. 
dysgalactiae (Group C Streptococcus, GCS) and Streptococcus uberis are relevant mastitis 
pathogens, a highly prevalent and costly disease in dairy industry due to antibiotherapy and loss 
in milk production. The aims of this study were the evaluation of antimicrobial drug resistance 
patterns, particularly important for streptococcal mastitis control and the identification of strain 
molecular features. Antimicrobial resistance was assessed by disk diffusion against amoxicillin-
clavulanic acid, cefazolin, cefoperazone, pirlimycin-PRL, rifaximin, streptomycin, 
chloramphenicol, erythromycin-ERY, gentamicin, tetracycline-TET and vancomycin. 
Genotypic relationships were identified using pulsed-field gel electrophoresis (PFGE), 
macrolide and/or tetracycline resistance gene profiling, GBS capsular typing, GBS virulence 
gene profiling and GBS and S. uberis multi locus sequence typing (MLST). 
The majority of the isolates were susceptible to all drugs except to aminoglycoside, macrolide, 
lincosamide and tetracycline. Close to half of the TET resistant isolates have tetO and tetK and 
almost all ERY-PRL resistant isolates have ermB. A high degree of intra-species polymorphism 
was found for GCS. The GBS belonged to ST-2, -554, -61, -23 lineages and five new molecular 
serotypes and human GBS insertion sequences in the cpsE gene were found. Also, GBS of 
serotype V with scpB and lmb seem to be related with GBS isolates of human origin (same ST-2 
and similar PFGE). Overall our results suggested that different therapeutic programs may have 
been implemented in the different farms and that in most cases clones were herd-specific. 
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5.1. Introduction 
 
Streptococcus agalactiae (Group B Streptococcus, GBS), Streptococcus dysgalactiae subsp. 
dysgalactiae (Group C Streptococcus, GCS), and Streptococcus uberis are pathogens most 
frequently associated with bovine mastitis, a highly prevalent and costly disease for the dairy 
industry due to antibiotherapy, milk production loss and other costs (Erskine et al., 2003). 
While S. uberis and S. dysgalactiae subsp. dysgalactiae are considered exclusively animal 
pathogens (Facklam et al., 2002; Vieira et al., 1998), S. agalactiae is also a human pathogen 
that causes severe invasive neonatal infections, infection in pregnant women and elderly people 
and causes mortality in immuno-compromised adults (Bisharat et al., 2004; Brochet et al., 
2006). 
Surveys carried out to investigate temporal changes in the microbial panorama aim to monitor 
the prevalence of contagious/ environmental agents associated with mastitis (Pitkälä et al., 
2004, Bexiga et al., 2005, Ericsson et al., 2009) including monitoring antimicrobial resistance 
since patterns of resistance may differ among different countries (Hendriksen et al., 2008). 
Also, molecular epidemiology tools offer unique opportunities to advance the study of diseases 
through the investigation of infectious agents at the molecular level in a veterinary context 
(Muellner et al., 2011). However, studies on the molecular characterization of field streptococci 
isolates occurring in Portugal, which is of utmost importance in order to implement efficient 
management practices in herds, are still not documented, with exception of S. uberis (Rato et 
al., 2008) and S. dysgalactiae subsp. dysgalactiae (Rato et al., 2010). 
The aims of this study were the evaluation of antimicrobial drug resistance patterns among S. 
agalactiae, S. dysgalactiae subsp. dysgalactiae and S. uberis and the identification of strain 
molecular features. 
 
5.2. Materials and Methods 
 
5.2.1. Bacterial isolates and identification 
 
 A total of 60 beta-hemolytic Streptococcus agalactiae of Lancefield group B (GBS), 18 alpha-
hemolytic S. dysgalactiae subsp. dysgalactiae of Lancefield group C (GCS), and 30 gamma-
hemolytic S. uberis field isolates from bovine subclinical mastitis were included in the present 
study. This collection comprised all streptococcal isolates (with the exception of 4 S. uberis 
isolates and 4 S. agalactiae isolates that were lost during storage) collected from January 2002 
to May 2003, from 444 bovine milk samples of 365 animals with subclinical mastitis, from 11 
herds located in the southwestern region of Portugal (Bexiga et al., 2005). The original study 
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(Bexiga et al., 2005) involved milk sampling of 459 quarters from 377 animals from a total of 
12 dairy herds. Among a total of 459 milk samples, 351 were positive for bacterial growth. Of 
those, S. dysgalactiae subsp. dysgalactiae was found in 5.1% of the samples, S. uberis in 10%, 
Staphylococcus aureus in 10%, Gram negative bacteria (including Escherichia coli) in 10%, 
and S. agalactiae in 18.2% (Bexiga et al., 2005). 
Further detailed information regarding the streptococcal field isolates that were included in the 
present work, isolation and identification methods has been previously described in the 
“materials and methods” section of Chapter 2. 
Confirmation of identification of S. agalactiae isolates was performed by Lancefield grouping 
with type B antisera (Slidex Strepto Kit, BioMérieux) and by a positive haemolytic result 
according to the CAMP test (Facklam, 2002), (see Fig.1.3 and Fig. 1.4; Chapter 1). Molecular 
identification of S. uberis and S. dysgalactiae subsp. dysgalactiae (GCS) field isolates was 
performed by sequencing and analysis of 16S rDNA gene as described previously (see Chapter 
2 and Chapter 3). 
 
5.2.2. Pulsed-field gel electrophoresis (PFGE) profiles and cluster analysis 
 
For the identification of clonal lineages, the percentage of similarity among DNA band patterns 
obtained by PFGE was determined by cluster analysis based in a dendrogram. Genotypic related 
groups or clusters, identified at 80% similarity or above (corresponding to variation up to six 
bands among patterns) are represented by dashed rectangles in the dendrogram, and determined 
as described previously (Chapter 2). 
 
5.2.3. Multilocus sequence typing (MLST) 
 
A group of 18 S. agalactiae (GBS) isolates out of 60 were analysed by MLST in the present 
work. These isolates were chosen taking into account the PFGE band-based dendrogram, and 
comprised isolates with PFGE patterns sharing approximately 100%, 90%, 80%, 70%, 60% and 
50% of similarity. DNA was extracted as described for Group A Streptococcus (described at 
http://www.cdc.gov/ncidod/biotech/strep/protocol_emm-type.htm). The primers used for PCR 
amplification and sequencing are available at the S. agalactiae MLST web site 
(http://pubmlst.org/sagalactiae/). Sequencing was performed by STAB-Vida (Lisbon, Portugal), 
and sequences were analysed by using the BioEdit sequence alignment editor version 7.0.0 
(Hall, 1999). The eBURST tool (http://eburst.mlst.net/) was used for assignment of predicted 
primary founder(s), clonal complexes or singletons (STs that cannot be assigned to any group).  
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5.2.4. Antimicrobial resistance patterns 
 
All S. uberis, S. dysgalactiae subsp. dysgalactiae and S. agalactiae isolates were tested by disk 
diffusion technique (Oxoid Ltd, Basingstoke, UK) according to the guidelines from the Clinical 
and Laboratory Standards Institute (CLSI, 2008) for antimicrobial susceptibility tests for 
bacteria isolated from animals. The following antimicrobials were selected for testing, based on 
several criteria: a) licensing for mastitis treatment in cattle [penicillin 10 units (P), cefazolin 30 
μg (KZ), cefoperazone 75 μg (CFP), pirlimycin 2 μg (PRL), gentamicin 10 μg (CN), 
streptomycin 10 μg (S), and amoxicillin-clavulanic acid 30 μg (AMC)]; b) use in human 
medicine [rifaximin 40 μg (RAX), erythromycin 15 μg (ERY), vancomycin 30 μg (VA), 
chloramphenicol 30 μg (CHL), tetracycline 30 μg (TET)]; and c) determine phenotypes for 
subsequent search for resistance determinants assumed to be located on genetic mobile elements 
(tetracycline and erythromycin). 
Resistance was determined by measurement of inhibition of growth around the antimicrobial 
disk according to the zone diameter interpretative standards of CLSI (2008), and when not 
available, according to the antimicrobials manufacturers’ instructions. 
 
5.2.5. Macrolide resistance phenotypes 
 
Resistance only to macrolides (M phenotype) or to macrolides, lincosamides and 
streptogramins-B (MLSB phenotype), either inducible (iMLSB) or constitutive (cMLSB), were 
evaluated among all streptococcal isolates from the present study, by a double-disk test with 
erythromycin 15 μg (ERY) and pirlimycin 2 μg (PRL) disks (Seppälä, 1993), (see Fig. 1.8; 
Chapter 1). Resistance only to lincosamides (L phenotype) and to lincosamides and 
streptogramins-A (LSA phenotype) reported previously, was also tested by the double-disk test 
(Malbruny et al., 2004). 
 
5.2.6. PCR detection of antimicrobial resistance genes 
 
The macrolide resistance genes mefA, ermA, and ermB, were searched for by PCR among all 
isolates presenting either the MLSB or M phenotypes (Pires et al., 2005). Tetracycline resistance 
genes tetM, tetO, tetT, tetW, tetL, tetQ, tetK and tetS were tested by PCR among all tetracycline-
resistant streptococcal isolates (Pires et al., 2005; Ng et al., 2001; Aminov et al., 2001). All 
isolates were tested for the presence of the lincosamide resistance gene linB (Bozdogan et al., 
1999). All isolates of L phenotype were screened for the presence of the streptogramin A 
resistance gene vgaB by PCR as previously described (Allignet & Solh, 1997). 
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Antimicrobial resistance genes analyzed by PCR and primers used were described in Table 3.2 
(Chapter 3). All negative results were confirmed in at least three independent assays. 
 
5.2.7. Capsular serotyping and genotyping of S. agalactiae and phylogenetic analysis 
of sequence data 
 
The 60 S. agalactiae isolates were serotyped by the standard method of slide agglutination using 
antisera of types Ia, Ib, and II to VIII (Essum, Umeå, Sweden) and by capsule genotyping by 
PCR amplification and sequencing of cpsD-cpsE-cpsF genes as described (Florindo et al., 
2010). Sequencing was performed by STAB Vida (Lisbon, Portugal) and sequence data was 
analysed using SeqMan, DNAstar (DNAstar Inc., Madison, WI) and BioEdit sequence 
alignment editor version 7.0.0 (Hall, 1999). 
Each bovine cpsD-cpsE-cpsF sequence was aligned with sequences of S. agalactiae reference 
strains of recognized serotypes (Ia, Ib, II, III-1, III-2, III-3, III-4 and IV to VII) in search for 
nucleotide polymorphisms as described previously (Florindo et al., 2010). This alignment (1634 
bp) was used to construct a phylogenetic tree by using the MEGA version 5 (Tamura et al., 
2011). The Maximum Parsimony method was used and Bootstrap values were calculated from 
1,000 replicates. The GenBank accession numbers of S. agalactiae reference strains used in the 
analysis are designated in the tree. 
Specific primers were designed for sequencing the insertion sequence elements detected in the 
cpsE of four bovine GBS isolates from the present study: cpsE2 (rev.) 5’-
TTATATCGCTGTCTGTATCTTG-3’, cpsE44-1 (for.) 5’-
GATCGCGCGATAAATTGTTTTAAA-3’, and cpsE44-2 (for.) 
5’GGGAATAAATCTCTTTCTAGTGAA’3’. 
 
5.2.8. PCR detection of virulence genes among S. agalactiae (GBS) 
 
The 60 bovine S. agalactiae isolates were screened by PCR for the presence of the human GBS 
C5a peptidase precursor gene (scpB) and the laminin-binding protein gene (lmb) using the 
primers: scpB (for.) 5’-CCAAGACTTCAGCCACAAGG-3’, scpB (rev.) 5’-
CAATTCCAGCCAATAGCAGC-3’, lmb (for.) 5’-AACCCCAAACAGCCTACGCAAG-3’, 
and lmb (rev.) 5’-TAAAACGGGATCCGTCCAGGTAT-3’ (see Table 4.1; Chapter 4). The 
presence of the insertion elements ISSag2 (known to flank the scpB-lmb region) and IS1548 or 
GBSi1 (located in the scpB-lmb intergenic region) were searched for by PCR as previously 
described (Franken et al., 2001; Safadi et al., 2010). The surface protein Spb gene (spb), and the 
fibrinogen-binding proteins FbsA and FbsB genes (fbsA and fbsB, respectively) were screened 
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by PCR as described previously (Brochet et al., 2006). All negative results were confirmed in at 
least three independent assays. 
 
5.3. Results 
 
5.3.1. Pulsed-field gel electrophoresis (PFGE) and cluster analysis among S. agalactiae, 
S. dysgalactiae subsp. dysgalactiae and S. uberis 
 
The PFGE band-based dendrogram for clonal assessment of the S. agalactiae isolates is shown 
in Fig. 5.1. Other genotypic characteristics of S. agalactiae and the farm codes of origin of each 
individual isolate were also included in Fig. 5.1. 
The 60 S. agalactiae isolates collected among six farms were resolved into 24 PFGE types. 
Epidemiologically plausible groups or clusters (identified at 80% of similarity or above) 
revealed four major clonal groups (see clusters I, VI, IX and X; Fig. 5.1) comprising close to 
50% of all bovine GBS isolates (all farm-associated). Other minor clusters, which included two 
to three isolates, were also identified and comprised 30% of total bovine GBS isolates (all farm 
associated). 
Two bovine GBS PFGE patterns (A-1 and B-1) showed nearly 90% similarity with two human 
GBS PFGE patterns (see Fig. 5.2), when representative PFGE patterns (38 types) of the bovine 
GBS isolates were compared in a dendrogram with 135 PFGE patterns of human GBS from a 
parallel study, involving vaginal and/or rectal swabs of pregnant women at five health 
institutions in Portugal for assessment of GBS carriage (Santos Sanches I. et. al., unpublished 
data). 
 
5.3.2. Multilocus sequence typing (MLST) 
 
A subset of bovine S. agalactiae isolates (n=18) out of a total of 60 (e.g., one isolate 
representative of each PFGE clonal group) were analysed by MLST. Among this subset of 
isolates four sequence types (ST) were identified (ST-2, ST-61, ST-23 and ST-554), of which 
ST-554 was found to be novel due to the identification of a new allele of one of the seven 
housekeeping genes (phes, allele 39). This novel ST-554 is a single locus variant-SLV of ST-61 
(Fig. 1.6; Chapter 1). The ST-61 belongs to clonal complex (CC) 61/67, ST-2 belongs to CC2 
and ST-23 belongs to CC23 as assessed by eBURST analysis (Fig. 1.6; Chapter 1). 
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5.3.3. Antimicrobial resistance traits and macrolide/tetracycline resistance phenotypes 
and genotypes among S. agalactiae, S. dysgalactiae subsp. dysgalactiae and S. uberis 
 
Among the 108 bovine isolates tested the highest antimicrobial resistance patterns were 
observed for streptomycin and gentamicin (97.2% and 80.6%, respectively) followed by 
tetracycline (64.8%). None of the streptococcal isolates tested showed resistance to vancomycin, 
chloramphenicol, penicillin, rifaximin, amoxicillin/clavulanic acid, cefazolin and cefoperazone 
(see Table 5.1). 
All isolates resistant to erythromycin and pirlimycin presented the cMLSB phenotype (Table 
5.2). The phenotype M (resistance to ERY only) was not detected among our streptococcal 
collection. A group of S. dysgalactiae subsp. dysgalactiae (n=3) and of S. uberis (n=8) isolates 
showed resistance to pirlimycin and susceptibility to erythromycin (L-phenotype). 
All isolates of the cMLSB phenotype carried either the ermB gene (GBS, n=10; GCS, n=3; S. 
uberis, n=8) or the ermA gene (GBS, n=1; GCS, n=1), while the macrolide resistance gene mefA 
was not detected. One of cMLSB (ermB+) isolates also carried the linB gene. Additionally, all 
isolates belonging to the L-phenotype (n=11) carried the linB gene. None of the isolates that 
were susceptible to pirlimycin (n=75; among 108 isolates) carry the linB gene in our collection. 
The streptogramin A resistance gene vgaB was not detected. All the tetracycline resistant 
isolates carried at least one of the tet genes tetM, tetO, tetK and tetS, with exception of six S. 
dysgalactiae subsp. dysgalactiae isolates, in which none of the tet genes tested were detected. 
The tetT, tetW, tetL and tetQ genes tested were not detected. 
 
5.3.4. Capsular serotyping and genotyping of S. agalactiae and phylogenetic tree of 
sequence data 
 
A great proportion (77%; n=46/60) of the bovine S. agalactiae isolates tested by the serologic 
method were nontypeable (NT), either due to the agglutination with multiple antisera or to the 
lack of agglutination with any of the antisera, and 14 isolates (23%) were identified as serotype 
V. 
Capsular genotyping of the cpsD-cpsE-cpsF region at the cps locus confirmed the serotype V of 
the 14 bovine isolates since sequences matched 100% with the cpsD-cpsE-cpsF of S. agalactiae 
reference strain of serotype V (GenBank accession number AF332910). One of the 46 NT 
isolates was identified as serotype III-3, since the cpsD-cpsE-cpsF region matched 100% with 
the same region of a S. agalactiae reference strain of sero-subtype III-3 (GenBank accession 
number AF332897). 
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Figure 5.1. Dendrogram of PFGE profiles of group B Streptococcus (Streptococcus agalactiae) from bovine 
mastitis, constructed using Dice coefficients and unweighted pair group method using arithmetic averages.
Clustering settings of 0.00% optimization and 1.5% band position tolerance were used. *Presence of a 
transposase in cpsE gene; **Presence of an integrase/recombinase in cpsE gene (see text); †All scpB+ and lmb+
isolates carry ISSag2, and do not carry IS1548 or GBSil elements. 
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Novel cpsD-cpsE-cpsF polymorphisms were detected among the remaining 45 NT isolates, 
corresponding to five new sequences found: cpsBOV New-1 (6 isolates), cpsBOV New-2 (11 
isolates), cpsBOV New-3 (24 isolates), cpsBOV New-4 (one isolate), and cpsBOV New-5 with an 
insertion sequence in the cpsE gene (three isolates). For a better understanding of the 
polymorphisms, a phylogenetic tree was constructed (see Fig. 5.3). 
Additionally, three bovine isolates had a 1051 bp insert in the cpsE gene, and one isolate (of 
cpsBOVNew-3) had a 1499 bp insert in the cpsE gene. By using the BLAST alignment tool 
(www.ncbi.nlm.nih.gov/BLAST) these inserts were identified as being an 
integrase/recombinase and a transposase (GenBank accession numbers: EFV96274 and 
EFV96282, respectively) of a human strain S. agalactiae ATCC 13813 from the oral cavity. 
The new bovine GBS capsular sequences found in the present study have been deposited in 
GenBank database under GenBank accession numbers JN384109, JN384110, JN384111, and 
JN384112 (see Annex). The bovine cpsD-cpsE-cpsF sequences containing the above mentioned 
insertion sequence elements were also deposited in GenBank database under the accession 
numbers JN384114 and JN384113 (see Annex). 
 
5.3.5. Virulence traits of bovine S. agalactiae  
 
The scpB and lmb genes and the insertion element ISSag2 were detected among 13 bovine 
isolates (of PFGE types A-1 and B-1, all from a same farm). The insertion sequences IS1548 
and GBSi1 tested by PCR were not found in the scpB-lmb intergenic region of these 13 isolates. 
The fbsB gene was present in all bovine S. agalactiae isolates while fbsA gene was not detected. 
The spb gene was detected in 60% (n=36) of bovine isolates. 
 
5.4. Discussion 
 
5.4.1. Epidemiological comparison between S. agalactiae, S. dysgalactiae subsp. 
dysgalactiae and S. uberis 
 
One of our aims was to evaluate the clonal distribution of a collection of streptococcal isolates 
recovered at different farms. In the present work we found frequent occurrence of 
indistinguishable PFGE profiles among S. agalactiae isolates collected from a same farm, and 
close to 50% of S. agalactiae isolates were included in four major clonal groups as assessed by 
PFGE (all farm-specific), (see Fig. 5.1). These results suggest widespread strain transmission 
between animals from the same farm. S. agalactiae is considered a contagious mastitis pathogen 
(Barkema et al., 2009) and our results seem to be in agreement with this view. 
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In contrast, the occurrence of PFGE patterns sharing >82.8% and 100% similarity among S. 
dysgalactiae subsp. dysgalactiae isolates collected at different farms (see Fig. 3.1; Chapter 3), 
suggests an environmental source for this pathogen. S. dysgalactiae subsp. dysgalactiae is 
considered a pathogen associated with teat lesions caused by flying insects (Yeruham et al., 
2002), emphasizing an environmental source for this pathogen in our case. 
Heterogeneity in S. uberis PFGE patterns was observed between isolates collected from 
different farms, while three PFGE types accounted for 46.6% of total isolates - all farm-
associated (Fig. 2.2; Chapter 2). Our results suggest direct transmission of S. uberis among 
animals within a same farm (Chapter 2). It is plausible that inadequate implementation of 
management programs for the control of contagious pathogens at farm level, may be promoting 
the contagious route for S. uberis infection within herds, despite it is considered an 
environmental pathogen (Ericsson et al., 2009). 
 
 
 
 
 
 
 
 
5.4.2. Similar clonal types found among bovine and human S. agalactiae 
 
The two PFGE clonal pairs of bovine and human S. agalactiae shared the same ST (ST-2) and 
one of the two PFGE clonal pairs also shared identical serotypes (V) (Fig. 5.2). These results 
suggest possible bovine-human transmission although this is unlikely in the present study due to 
geographical distance and lack of epidemiological data regarding these bovine and human 
isolates in particular. Nevertheless, previous observation of possible transmission of GBS 
between humans and bovines has been reported (Manning et al., 2010). 
 
 Streptococcus 
agalactiae (n=60) 
Streptococcus dysgalactiae subsp. 
dysgalactiae (n=18) 
Streptococcus 
uberis 
(n=30) 
Total 
 
 
 
(n=108) 
ERY 18,3 22,2 26,7 21,3 
PRL 18,3 38,9 53,3 31,5 
TE 56,7 100 60 64,8 
CN 93,3 38,9 80 80,6 
S 96,7 77,8 100 97,2 
CFP 3,3 0 3,3 2,8 
*Resistance was not observed against vancomycin (VA), chloramphenicol (CHL), penicillin (P), 
amoxicillin-clavulanic acid (AMC), cefazolin (KZ) and rifaximin (RAX). 
Table 5.1. Percentages of antimicrobials resistance of Streptococcus agalactiae, Streptococcus 
dysgalactiae subsp. dysgalactiae and Streptococcus uberis isolates from the present study against the 
antimicrobials: erythromycin (ERY), pirlimycin (PRL), tetracycline (TET), gentamicin (CN), 
streptomycin (S) and cefoperazone (CFP)*. 
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Figure 5.2. Features of similar clonal types between two bovine S. agalactiae (GBS) isolates from the 
present study and two human S. agalactiae (GBS) isolates collected from rectal/ vaginal swabs 
(colonization) of pregnant woman, among five health institutions in Portugal. The dendrogram included 
representative PFGE patterns (<100% similarity) of bovine GBS (n=38) and 135 representative PFGE 
patterns of human GBS isolates. Features of the bovine isolates from the present study are designated in 
bold in the figure. Dice coefficients and unweighted pair group method using arithmetic averages (and 
clustering settings of 0.00% optimization and 1.5% band position tolerance) was used to construct the 
dendrogram. hum: human; bov: bovine. 
5.4.3. Multilocus sequence typing (MLST) of S. agalactiae and S. uberis 
 
Among S. agalactiae isolates four STs (ST-61, ST-2, ST-23 and ST-554) were detected, which 
belong to three clonal complexes (CC2, CC23 and CC61/67), (Fig. 1.6; Chapter 1). These 
results indicate little heterogeneity among our S. agalactiae collection, which was also 
supported by the PFGE results. Similar results were reported in a previous work (Bisharat et al., 
2004). 
The 30 S. uberis isolates tested by MLST revealed 14 different ST (all new) of which almost all 
are singletons, as determined by e-BURST analysis (Chapter 2). Only ST-287 is a SLV of a 
predictor founder of a major e-BURST group, which has been previously described in a S. 
uberis isolate from bovine mastitis in Australia, suggesting a common source disseminated to 
such distant locations in consequence of cattle global trading (Fig. 2.3; Chapter 2). Absence in 
finding identical ST between S. uberis isolates from the present study with those described so 
far in other countries may be due to the lack of information regarding population structure of S. 
uberis isolates from Southern European countries in the MLST database 
(http://pubmlst.org/suberis/). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5.4.4. Antimicrobial resistance traits and genotypes of S. agalactiae, S. dysgalactiae 
subsp. dysgalactiae and S. uberis 
 
Updated information regarding published veterinary breakpoints for mastitis pathogens is 
required to validate the clinical relevance of in vitro susceptibility testing results for these 
Host 
Strain name (hum) 
/PFGE Type-
subtype (bov) 
Clinical 
origin Serotype 
Antimicrobial 
resistance 
phenotype 
SmaI PFGE 
profiles 
% similarity MLST 
88.9
79
69
88.9
65.9
B-1
HAS642
GO19
A-1
Mastitis
Vaginal/rectal 
GBS-Bovine
GBS-Human
GBS-Bovine
GBS-Human
Mastitis
Vaginal/rectal 
V
V
III
V
cMLSB + TET
iMLSB
TET only
TET only
ST-2
ST-2
ST-2
ST-2
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pathogens. In order to have a global view of antimicrobial resistance occurrence among isolates 
of the three bovine streptococcal species, all isolates from the present study were tested by the 
in vitro disk diffusion method (CLSI, 2008) against 13 antimicrobials, which were chosen 
taking into account their availability in the Portuguese market for intramamary treatment of 
mastitis and also in order to monitor the erythromycin and tetracycline resistance phenotypes 
and genotypes among bovine streptococci. 
Interpretative standards (breakpoints) were used according to what is available in the CLSI 
(2008), and when not available according to the antimicrobials manufacturers’ instruction. 
 
 
 
 
 
 
 
 
Overall, resistance to the aminoglycoside antimicrobials, gentamicin and streptomycin, was 
high (80.6% and 97.2% respectively) while penicillin, amoxicillin-clavulanic acid, cefazolin, 
cefoperazone chloramphenicol, vancomycin and rifaximin showed very good in vitro efficacy 
against our streptococcal collection. 
No. (%) of resistant isolates carrying resistance genes** 
ERY resistance 
genes  
PRL 
resistance 
gene 
 TET resistance genes 
Species 
(No. 
total 
isolates) 
Resistance 
phenotype* Total 
ermA ermB  linB  tetM tetO tetK tetS 
cMLSB only 1 0 
1 
(100)  0  nd nd nd nd 
cMLSB+TET 10 1 (10) 9 (90)  0  1 (10) 9 (90) 
10 
(100) 0 
GBS 
(n=60) 
TET only 24 nd nd  0  12 (50) 11 (45,8) 
24 
(100) 0 
cMLSB+TET 4 1 (25) 3 (75)  0  1 (25) 3 (75) 0 0 
L+TET 3 nd nd  3 (100)  1 (33,3) 2 (66,7) 0 0 GCS (n=18) 
TET only 11 nd nd  0  4 (36,4) 1 (9,1) 0 0 
cMLSB+TET 8 0 
8 
(100)  1 (13)  0 8 (100) 0 0 
L 1 nd nd  1 (100)  nd nd nd nd 
L+TET 7 nd nd  7 (100)  0 1 (14,3) 0 7 (100) 
S. uberis 
(n=30) 
TET only 3 nd nd  0  2 (66,7) 0 0 
1 
(33,3) 
Table 5.2. Distribution of erythromycin (ERY), pirlimycin (PRL) and tetracycline (TET) resistance 
phenotypes and genotypes among bovine Streptococcus agalactiae (GBS), Streptococcus dysgalactiae 
subsp. dysgalactiae (GCS) and Streptococcus uberis isolates. 
 
*Phenotype M was not found among the bovine isolates. 
**The mefA, vgaB, tetT, tetW, tetL, and tetQ antimicrobial-resistant genes were not detected. 
cMLSB only, constitutive MLSB resistance phenotype only; cMLSB + TET, constitutive MLSB resistance 
phenotype, and resistance to tetracycline; TET only, resistance only to tetracycline; L + TET, resistance to 
pirlimycin, susceptibility to erythromycin, and resistance to tetracycline; L, resistance to pirlimycin, and 
susceptibility to erythromycin only; 
nd, not determined 
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High percentages of resistance to tetracycline (64.8 to 100%) were observed among all the 
isolates, which may be due to the fact that tetracycline had been widely used for treatment of 
several infections in cattle for many years. 
These results were similar to what was described previously in other countries (Hendriksen et 
al., 2008; Petrovski et al., 2011), with exception of erythromycin and pirlimycin 
antimicfronbials. In the presence study we observed that resistance to these antimicrobials was 
high, which underlines the importance of locally monitoring resistance patterns rather than 
extrapolating results obtained in other countries. 
Co-resistance to erythromycin and pirlimycin observed was mostly due to the presence of ermB 
gene. Also, putative linkage of ermB and tetO antimicrobial resistance genes in unique strains 
(considered unrelated as assessed by PFGE) suggested horizontal co-transference of these genes 
in a same mobile genetic element. 
Additionally, resistance to pirlimycin was particularly high among S. uberis (53,3%) and S. 
dysgalactiae subsp. dusgalactiae (38,9%) due to the presence of linB gene, which is carried by a 
plasmid  first described in human strains of Enterococcus faecium (Bozdogan et al., 1999). 
Enterococcus faecium is also a recognized pathogen associated with bovine mastitis. 
These results underline the importance of surveillance of antimicrobial resistance genes among 
field isolates. 
 
5.4.5. Novel cps locus polymorphisms in nontypable bovine S. agalactiae and 
insertion sequence elements in cpsE 
 
By using the serologic method we identified 14 bovine S. agalactiae isolates as being of 
serotype V while the remaining 46 isolates (77%) were considered nontypable (NT). Indeed, 
high percentage of nontypeability among S. agalactiae isolates from bovine origin has been 
reported (Zhao et al., 2006). 
By molecular serotyping, one of the NT isolates was identified as being of molecular sero-
subtype III-3, while the remaining 45 NT isolates showed novel cpsD-cpsE-cpsF sequence 
polymorphisms and did not match completely with any of the recognized molecular serotypes 
(Ia, Ib, II, III-1, III-2, III-3, III-4 and IV to IX). Further studies are required in the future to 
assess if the above mentioned polymorphisms observed in the bovine strains are associated with 
new functional proteins (represent new serotypes). 
In the phylogenetic tree (Fig. 5.3), all these novel bovine cpsD-cpsE-cpsF sequences clustered 
together in a clade but separately from the remaining serotypes from human S. agalactiae 
reference strains, suggesting they have diverged within the bovine host and that they do not 
represent subtypes of known molecular serotypes from human S. agalactiae. 
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 cps BOV New-3* 
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 cps BOV New-2 
 cps BOV New-1 
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 cps III-2 (AF332896) 
 cps VI (AF337958) 
 cps Ib (AF332903) 
 cps V (AE009948) 
 cps V (AF349539)  
 cps V (AF332910)  
 cps BOV  V 
99
76
93
86
84
70
63
51
46 
44 
41
23 
31 
83 
67
89
2 
Polymorphic sites: 4 
Polymorphic sites: 2
Polymorphic sites: 12
Polymorphic sites: 15 
Polymorphic sites: 27 
The inserts found in the cpsE gene (a transposase and an integrase/recombinase of S. agalactiae 
ATCC 13813) of four bovine isolates from the present study illustrate the occurrence of recent 
genetic events, since only four out of the 60 bovine isolates (7%) carry these inserts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other authors have reported an insert (IS1381) in the cpsE gene of cps locus in a human S. 
agalactiae strain, which resulted in reduced or disrupted expression of the capsule 
polysaccharide (Ramaswamy et al., 2006). Presence of another insert (ISSa4) in the cpsE gene 
Figure 5.3. Phylogenetic analysis of cpsD-cpsE-cpsF sequences of bovine Group B Streptococcus 
(Streptococcus agalactiae) isolates and cpsD-cpsE-cpsF sequences of S. agalactiae reference strains, 
which were available in National Center for Biotechnology Information (NCBI) (Bethesda, MD). Bovine 
sequences from the present study are designated in bold in the tree. GenBank accession numbers of 
Streptococcus agalactiae reference strains are designated in parentheses in front of serotype designation. 
*One bovine isolate of molecular serotype cps BOV New-3 has an insert in cpsE (mutator family 
transposase of human S. agalactiae ATCC 13813); 
**All bovine isolates of molecular serotype cps BOV New-5 have an insert in cpsE (integrase/recombinase 
of human strain S. agalactiae ATCC 13813), (see text). 
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of three human GBS isolates has also been observed (Florindo et al., unpublished). Probably the 
frequency of inserts in cpsE among bovine isolates is higher than in human isolates, and may 
reflect evolutionary adaptation to the bovine host. However, further studies using bovine GBS 
isolates are needed to elucidate this issue. Few reports have decribed so far the presence of 
insertion sequences in bovine S. agalactiae strains (Shakleina et al., 2004; Richards et al., 
2011). 
 
5.4.6. Virulence traits among S. agalactiae 
 
The lmb and scpB virulence genes were found among 13 bovine isolates (22% of total isolates) 
despite the fact that these genes are described as usually absent in bovine GBS isolates (Franken 
et al., 2001; Safadi et al., 2010). Absence of the scpB - lmb region in the remaining bovine 
isolates (n=47) from the present work is probably due to deletion during putative adaptation to 
the bovine host. 
An association of spb gene with the clonal complex 17 (CC17) isolates has been previously 
reported (Brochet et al., 2006). The CC17 lineage is known to be closely related to CC61 
lineage (as assessed by eBURST; Fig. 1.6; Chapter 1), which may help to explain why we have 
detected the spb virulence gene only among GBS isolates of ST-61/ST-554 in the present study. 
 
5.5. Conclusions 
 
In conclusion, our results showed that our bovine streptococci were susceptible to clinical 
relevant antimicrobials; however resistance levels against erythromycin and pirlimycin in 
particular, were high when compared with data from other countries. 
Also we observed that our bovine S. agalactiae are homogenous within herds emphasizing its 
contagious nature. Few of these bovine isolates have several genotypic characteristics in 
common with human GBS collected from rectal/vaginal swabs. 
Our study highlights novel information regarding features of bovine S. agalactiae, namely the 
presence of insertion sequences in the cpsE gene from the cps locus which probably prevents 
expression of the capsule polysaccharide, and new cpsD-cpsE-cpsF sequences that may code for 
new serotypes. 
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6.1. Molecular epidemiology 
 
Continuous surveillance of bovine mastitis pathogens and herd careful management is essential 
for the well being of dairy cows and prevention of economic loss in the dairy industry. One of 
the aims of the present study was to study the clonal features of streptococcal field isolates 
associated with bovine mastitis in Portugal in order to contribute to improvement of bovine 
health. 
The PFGE and MLST approaches were suitable for the comparative analysis. Indeed, among S. 
uberis isolates, three PFGE clonal groups (associated with MLST lineages ST-265, ST-268, and 
ST-267) comprised >60% of total isolates, and among S. galactiae isolates only three MLST 
lineages (ST-2, ST-23, and ST-61/ST-554) were identified, which is indicative of a contagious 
route of transmission between animals (Chapter 2 and Chapter 5). These results suggest that 
control measures for these two pathogens in herds in Portugal deserve more attention. 
We identified identical PFGE patterns between S. dysgalactiae subsp. dysgalactiae isolates 
from different farms, which suggest an environmental source for this pathogen (see Chapter 3 
and Chapter 5). 
 
6.2. Host adaptation 
 
We observed that a group of the bovine S. agalactiae isolates (of PFGE types A-1 and B-1) 
showed features of human S. agalactiae, namely carried the lmb-scpB virulence genes. These 
genes are usually absent in S. agalactiae isolates from bovine origin but always present in 
human S. agalactiae, and are considered required for human isolates to infect the human host 
(Safadi et al., 2010). The remaining bovine GBS isolates from the present study lacked the lmb-
scpB virulence genes, which were probably lost during the adaptation to the bovine host. 
We also observed that the above mentioned bovine GBS clones (A-1 and B-1) which carry the 
lmb-scpB virulence genes, showed higher similarity (above 88% between PFGE patterns) with 
human S. agalactiae isolates collected from vaginal/rectal swabs from a parallel study, than 
with the remaining bovine isolates from the present study (Chapter 5). However, in the present 
case human-bovine transmission is most unlikely to have occurred due to the geographic 
distance between these (bovine and human) isolates sharing similar genotypes. Nevertheless, a 
recent study has documented the occurrence of similar S. agalactiae genotypes between isolates 
collected from humans and their bovines (which were in direct contact), and it was suggested 
that possible transmission between the two hosts occurs (Manning et al., 2010). 
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We identified new cpsD-cpsE-cpsF sequences (of the cps locus encoding the capsular 
polysaccharide) among the bovine S. agalactiae, suggesting novel serotypes not yet described. 
By phylogenetic analysis, we observed that all the new bovine cpsD-cpsE-cpsF sequences 
clustered together in a clade but separated from the human molecular serotypes, indicating that 
these new serotypes diverged in the bovine host. 
We further detected the presence of insertion sequences (so far described in human S. 
agalactiae) in the cpsE gene of the cps locus in few bovine S. agalactiae strains (Chapter 5). 
These inserts in cpsE probably disrupt the expression of the capsule polysaccharide in these 
bovine strains (which may result in phenotypic variation); however, further studies are 
necessary to confirm this hypothesis. 
 
6.3. Phenotypes and genotypes of antimicrobial resistance 
 
Importantly, all streptococcal isolates were susceptible to penicillin, cefoperazone and cefazolin 
antimicrobials, commonly used in bovine mastitis treatment in Portugal (Chapter 5). However, 
resistance to pirlimycin was very high (when compared to other countries), which is also an 
antimicrobial available for use in bovine mastitis treatment in Portugal. This observation points 
out the importance of locally monitoring antimicrobial resistance patterns for the improvement 
of antibiotherapy programmes, rather than extrapolating from results obtained in other 
countries. 
The putative linkage between antimicrobial resistance genes, namely ermB-tetO observed 
among unrelated and related bovine streptococcal isolates (as assessed by PFGE), suggests 
possible co-transference of these antimicrobial resistance determinants via horizontal gene 
transfer by a same mobile genetic element. Future studies should clarify which mobile genetic 
elements are putatively involved in such events. 
 
6.4. Phages and other mobile genetic determinants in bovine streptococci evolution 
 
We demonstrated that the bovine S. dysgalactiae subsp. dysgalactiae strains carried the S. 
pyogenes phage-associated virulence genes speK, speM, speL, speC, spd1, sdn. All these genes 
were transcribed by RT-PCR (Chapter 3 and Chapter 4). These genes encode pyrogenic-toxin-
superantigens, DNAses and streptodornases strongly associated with invasive disease in 
humans. These results suggest that S. pyogenes bacteriophages may play a role in the dynamics 
of bovine S. dysgalactiae subsp. dysgalactiae population structure. 
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Chapter 6 
Further investigation should be performed in order to clarify the role of phages in the lateral 
gene transfer between the animal and human streptococci, and in putatively increasing the 
pathogenesis of the bovine S. dysgalactiae subsp. dysgalactiae. 
Preliminary results in induction of prophages carried out after treatment with mitomycin C in 
two bovine S. dysgalactiae subsp. dysgalactiae strains from the present study (which carry 
speM, speC, speK, speL, spd1 phage-genes) has confirmed that those strains are lysogenic for 
viable phages (see Fig. 6.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In addition, by successfully amplifying the left junction of the Tn1207.3/Φ10394.4 mobile 
element in the bovine S. dysgalactiae subsp. dysgalactiae indicates that a Tn1207.3/Φ10394.4-
related chimeric element may be inserted in the comEC locus as previously described for the 
human pathogens S. pyogenes, S. dysgalactiae subsp. equisimilis and S. agalactiae (Chapter 3). 
By using an array of S. pyogenes virulence genes, we were able to compare genomic content of 
the bovine S. dysgalactiae subsp. dysgalactiae isolates with the human S. pyogenes, and human 
S. dysgalactiae subsp. equisimilis isolates. Thus, we further demonstrated that other relevant S. 
pyogenes virulence determinants which are transferred by integrative conjugative elements 
(namely the R28 protein) were also present in the bovine S. dysgalactiae subsp. dysgalactiae 
(Chapter 4). 
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Figure 6.1. Induction of prophages after treating cultures with mitomycin C in bovine S. dysgalactiae 
subsp. dysgalactiae strains GCS-Bov11 (which carries the phage-genes speM, speC, speK, spd1) and 
GCS-Bov13 (which carries the phage-genes speM, speC, speK, speL, spd1), and control strains lysogenic 
for speC phage (S. pyogenes or GAS) and lysogenic for IG3 phage (Bacillus subtillis). 
Mitomycin C was added to cultures incubated at 37ºC in Todd Hewitt broth, after 2 hours of growth 
(GCS-Bov13, GAS speC+ and Bacillus IG3+), and after 3 hours of growth (GCS-Bov11). 
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We have reported for the first time the presence of the human S. pyogenes (GAS) phage 
virulence genes among bovine S. dysgalactiae subsp. dysgalactiae (GCS). However it is still 
unclear whether these mobile genetic elements contribute to the increased virulence potential of 
this bovine streptococcal species. Moreover, conclusive evidence of S. dysgalactiae subsp. 
dysgalactiae as an infection agent in humans has not yet been proved. 
 
In the future it would be of utmost interest to further study strains of bovine S. dysgalactiae 
subsp. dysgalactiae, as well strains of the other human related subspecies - S. dysgalactiae 
subsp. equisimilis and S. pyogenes in order to assess the genomic structure of the phages 
carrying the detected virulence genes. This study would clarify whether the prophages carried 
by the animal GCS, the S. dysgalactiae subsp. equisimilis, and S. pyogenes strains are the same 
and thus defining phage(s) host range. The phage(s) isolation and charaterization could also 
contribute to the clarification of the involvement of those phages in mobile genetic transfer.  
 
It would be of interest to confirm if the bovine isolates carrying GAS virulence genes are 
expressing these genes at the proteomic level, and to test the bovine strains infection potential in 
vitro by using human cell lines and in vivo using Zebrafish (as a model for the evaluation of 
virulence). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Future perspectives 
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Nucleotide sequence accession numbers 
 
Sequence data have been deposited in GenBank (http://www.ncbi.nlm.nih.gov/genbank/) under 
the following accession numbers: 
 
 
JF789447 
Streptococcus dysgalactiae subsp. dysgalactiae strain 06.1563 16S ribosomal RNA gene, 
partial sequence 
JF789445 
Streptococcus dysgalactiae subsp. dysgalactiae strain 06.1563 SodA (sodA) gene, partial cds 
HQ724300 
Streptococcus dysgalactiae subsp. dysgalactiae pyrogenic exotoxin K (speK) gene, speK-1 
allele, partial cds 
HQ724301 
Streptococcus dysgalactiae subsp. dysgalactiae pyrogenic exotoxin K (speK) gene, speK-2 
allele, partial cds 
HQ724302 
Streptococcus dysgalactiae subsp. dysgalactiae pyrogenic exotoxin K (speK) gene, speK-3 
allele, partial cds 
HQ724303 
Streptococcus dysgalactiae subsp. dysgalactiae pyrogenic exotoxin L (speL) gene, speL-1 
allele, partial cds 
HQ724304 
Streptococcus dysgalactiae subsp. dysgalactiae pyrogenic exotoxin M (speM) gene, speM-1 
allele, partial cds 
HQ724305 
Streptococcus dysgalactiae subsp. dysgalactiae pyrogenic exotoxin M (speM) gene, speM-2 
allele, partial cds 
HQ696925 
Streptococcus dysgalactiae subsp. dysgalactiae strain VSD16 pyrogenic exotoxin C (speC) 
gene, speC-1 allele, partial cds 
JF789444 
Streptococcus dysgalactiae subsp. dysgalactiae strain VSD1 SagA (sagA) gene, partial cds 
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JF789442 
Streptococcus dysgalactiae subsp. dysgalactiae strain 06.1563 SagA (sagA) gene, partial cds 
JF789443 
Streptococcus dysgalactiae subsp. dysgalactiae strain DB49998/05 SagA (sagA) gene, partial 
cds 
JN384109 
Streptococcus agalactiae strain VSA12 capsular polysaccharide biosynthesis gene cluster, 
partial sequence (cps-1BOV) 
JN384110 
Streptococcus agalactiae strain VSA1 capsular polysaccharide biosynthesis gene cluster, 
partial sequence (cps-2BOV) 
JN384111 
Streptococcus agalactiae strain VSA3 capsular polysaccharide biosynthesis gene cluster, 
partial sequence (cps-3BOV) 
JN384112 
Streptococcus agalactiae strain VSA17 capsular polysaccharide biosynthesis gene cluster, 
partial sequence (cps-4BOV) 
JN384113 
Streptococcus agalactiae strain VSA44 capsular polysaccharide biosynthesis gene cluster, 
partial sequence (cps-3BOV with insertion sequence) 
JN384114 
Streptococcus agalactiae strain VSA10 capsular polysaccharide biosynthesis gene cluster, 
partial sequence (cps-5BOV with insertion sequence) 
 
 
 
 
 
 
 
 
 
 
 
 
 
